Patent Grant
11375941
For purposes of this disclosure, certain aspects, advantages, and novel features of various embodiments are described herein. It is to be understood that not necessarily all such advantages may be achieved in accordance with any particular embodiment. Thus, various embodiments may be or carried out in a manner that achieves one advantage or group of advantages as taught herein without necessarily achieving other advantages as may be taught or suggested herein.
Embodiments described herein are directed to a physiological monitoring device that may be worn continuously and comfortably by a human or animal subject for at least one week or more and more typically two to three weeks or more. In one embodiment, the device is specifically designed to sense and record cardiac rhythm (for example, electrocardiogram, ECG) data, although in various alternative embodiments one or more additional physiological parameters may be sensed and recorded. Such physiological monitoring devices may include a number of features to facilitate and/or enhance the patient experience and to make diagnosis of cardiac arrhythmias more accurate and timely.
Some embodiments include a wearable cardiac monitor device for monitoring cardiac rhythm signal data of a user, the wearable cardiac monitor device comprising: a watertight housing; a surface on the housing configured to be sealably engaged to a mammal; an adhesive on the surface configured to remain continuously affixed to the mammal for at least 7 days, without removal until completion of monitoring; at least two electrodes permanently disposed within the housing, positioned to detect continuous cardiac rhythm signals of the mammal while the surface is sealably engaged to the mammal; a hardware processor configured to process the detected cardiac rhythm signals through a first subset of computer-executable instructions; and a transmitter, the transmitter configured to transmit the output of the first subset to a computing system, the computing system configured to infer a likelihood of an occurrence of cardiac arrhythmia by processing the output through a second subset of computer-executable instructions.
In some embodiments, the arrhythmia comprises at least one of: ventricular tachycardia, supraventricular tachycardia, ectopy, ventricular fibrillation, or extended pauses.
In some embodiments, to infer a likelihood of an occurrence of cardiac arrhythmia comprises processing the output of the first subset through the second subset, wherein the first subset processed at least 24 hours of continuously detected, stored cardiac rhythm signals.
In some embodiments, the housing comprises a patient trigger configured to depress and initiate recordation of an instance in time of a perceived cardiac event.
In some embodiments, the electrodes are disposed entirely within the housing.
In some embodiments, the first subset of computer-executable instructions comprise a first subset of layers of a neural network, wherein the second subset of computer-executable instructions comprise a second subset of layers of the neural network.
Some embodiments include a wearable cardiac monitor device for monitoring bio-signal data of a user, the wearable device comprising: an adhesive assembly comprising a housing and a wing, the wing comprising an electrode configured to detect cardiac signals from a user; a hardware processor configured to process the detected cardiac signals through a first subset of layers of a neural network; and a transmitter, the transmitter configured to transmit the output of the first subset to a computing system, the computing system configured to infer a likelihood of an occurrence of cardiac arrhythmia by processing the output through a second subset of layers of the neural network.
In some embodiments, the computing system is further configured to determine an atrial fibrillation burden from the detected cardiac signals.
In some embodiments, the atrial fibrillation burden comprises an amount of time spent in atrial fibrillation by the user during a period of time.
In some embodiments, the atrial fibrillation burden comprises an amount of time spent in atrial fibrillation by the user during a sleep period and during a wake period.
Some embodiments include a wearable device for monitoring bio-signal data of a user, the wearable device comprising: an assembly comprising an electrode configured to detect cardiac signals from a user; a hardware processor configured to process the detected cardiac signals through a first subset of layers of a neural network; and a transmitter, the transmitter configured to transmit the output of the first subset to a computing system, the computing system configured to infer a likelihood of an occurrence of cardiac arrhythmia by processing the output through a second subset of layers of the neural network.
In some embodiments, the hardware processor is configured to process the detected cardiac signals through the first subset of layers of the neural network continuously in substantially real-time of detecting ECG signals.
In some embodiments, the output of the first subset of layers of the neural network comprises an indication of an R peak.
In some embodiments, the computing system is further configured to reconstruct the cardiac signals via the second subset of layers.
In some embodiments, the output of the first subset of layers of the neural network is of a smaller dimensionality than the input of the first subset of layers of the neural network.
In some embodiments, the hardware processor is configured to select the neural network from a plurality of neural networks based on a characteristic.
In some embodiments, the characteristic comprises at least one of: a characteristic of the wearable device, a network characteristic between the wearable device and the computing system.
In some embodiments, the hardware processor is further configured to compress the output of the first subset of layers of the neural network, wherein to transmit the output of the first subset to the computing system comprises transmitting the compressed output, wherein the computing system is configured to decompress the transmitted data; and wherein processing the output through the second subset of layers comprises processing the decompressed data.
In some embodiments, the hardware processor is further configured to quantize the output of the first subset of layers of the neural network, wherein to transmit the output of the first subset to the computing system comprises transmitting the output.
In some embodiments, the hardware processor is further configured to compress the quantized output, wherein to transmit the output of the first subset to the computing system comprises transmitting the compressed output, wherein the computing system is configured to decompress the transmitted data; and wherein processing the output through the second subset of layers comprises processing the decompressed data.
In some embodiments, to transmit the output of the first subset to the computing system comprises transmitting the quantized output.
Some embodiments include a monitor to infer a likelihood of a characteristic of a user, the monitor comprising: a housing; at least two electrodes permanently disposed within the housing, positioned to detect continuous signals of a surface; a printed circuit board assembly comprising a hardware processor configured to process the detected signals through a first subset of computer executable instructions; and a transmitter, the transmitter configured to transmit the data output of the first subset of computer executable instructions to a computing system, the computing system configured to infer a likelihood of an occurrence by processing the data output through a second subset of computer executable instructions.
In some embodiments, the dimensionality of the data output of the first subset of the computer executable instructions that is transmitted to the computing system is smaller than the data of the detected signals from the at least two electrodes.
In some embodiments, the data output of the first subset of the computer executable instructions is encrypted, wherein the transmitter transmits the encrypted data output, wherein the computing system processes the encrypted data output through the second subset of computer executable instructions.
In some embodiments, the transmitter transmits the data output to the computing system via a wireless communication channel.
In some embodiments, the monitor further comprises a receiver configured to receive an updated first subset of computer executable instructions from the computing system and updating the first subset of the computer executable instructions to the updated first subset of computer executable instructions, wherein the hardware processor is further configured to process signals through the updated first subset of computer executable instructions.
In some embodiments, the monitor further comprises an accelerometer configured to gather motion data, wherein the computing system is configured to match motion data with the detected signals to infer the likelihood of the occurrence.
In some embodiments, the monitor is a cardiac monitor, wherein the continuous signals are cardiac signals, wherein the occurrence is an arrhythmia event.
In some embodiments, the first subset of computer executable instructions comprise a first subset of layers of a neural network, and the second subset of computer executable instructions comprise a second subset of layers of the neural network.
Some embodiments include a monitor to infer a likelihood of a characteristic of a user, the monitor comprising: a watertight housing; a surface on the housing configured to be sealably engaged to a mammal; an adhesive on the surface configured to remain continuously affixed to the mammal for at least 7 days, without removal until completion of monitoring; at least two electrodes permanently disposed within the housing, positioned to detect continuous cardiac rhythm signals of the mammal while the surface is sealably engaged to the mammal; a printed circuit board assembly comprising a hardware processor configured to process the detected cardiac rhythm signals through a first subset of computer executable instructions; and a transmitter, the transmitter configured to transmit the data output of the first subset of computer executable instructions to a computing system, the computing system configured to infer a likelihood of an occurrence of arrhythmia by processing the data output through a second subset of computer executable instructions.
In some embodiments, the arrhythmia comprises at least one of: ventricular tachycardia, supraventricular tachycardia, ectopy, ventricular fibrillation, or extended pauses.
In some embodiments, to infer a likelihood of an occurrence of cardiac arrhythmia comprises processing the output of the first subset through the second subset, wherein the first subset processed at least 24 hours of continuously detected, stored cardiac rhythm signals.
In some embodiments, the housing comprises a patient trigger configured to depress and initiate recordation of an instance in time of a perceived cardiac event.
Some embodiments include a system for training a neural network to infer a likelihood of a characteristic of a user, the system comprising: a wearable device comprising: an assembly comprising an electrode configured to detect cardiac signals from a user; a hardware processor configured to process the detected cardiac signals through a first subset of layers of a neural network; and a transmitter, the transmitter configured to transmit the output of the first subset to a computing system, the computing system configured to infer a likelihood of an occurrence of cardiac arrhythmia by processing the output through a second subset of layers of the neural network, wherein the system is configured to train the neural network by: training a first neural network to identify a first feature by processing first training data of a first time period through the first neural network; freezing weights of the first neural network; training a second neural network to identify a second feature by processing second training data of a second time period through the first and second neural network, wherein the second time period is longer than the first time period; unfreezing weights of the first neural network; and training the first and second neural network simultaneously to identify the second feature by processing third training data of a third time period through the first and second neural network, wherein the third time period is longer than the first time period.
In some embodiments, the output of the first subset of layers of the neural network is of a smaller dimensionality than the input of the first subset of layers of the neural network.
In some embodiments, the hardware processor is configured to select the neural network from a plurality of neural networks based on a characteristic.
In some embodiments, the characteristic comprises at least one of: a characteristic of the wearable device, a network characteristic between the wearable device and the computing system.
In some embodiments, the hardware processor is further configured to compress the output of the first subset of layers of the neural network, wherein to transmit the output of the first subset to the computing system comprises transmitting the compressed output, wherein the computing system is configured to decompress the transmitted data; and wherein processing the output through the second subset of layers comprises processing the decompressed data.
In some embodiments, the hardware processor is further configured to quantize the output of the first subset of layers of the neural network, wherein to transmit the output of the first subset to the computing system comprises transmitting the output.
Some embodiments include a method for training a neural network to infer a likelihood of a characteristic of a user, the method comprising: training a first neural network to identify a first feature by processing first training data of a first time period through the first neural network; freezing weights of the first neural network; training a second neural network to identify a second feature by processing second training data of a second time period through the first and second neural network, wherein the second time period is longer than the first time period; unfreezing weights of the first neural network; and training the first and second neural network simultaneously to identify the second feature by processing third training data of a third time period through the first and second neural network, wherein the third time period is longer than the first time period.
In some embodiments, the second training data is the third training data, and the second time period is the third time period.
In some embodiments, training is based on available processing power of a wearable device.
In some embodiments, training is based on available memory of a wearable device.
In some embodiments, training is based on network availability between a wearable device and an external computing system.
In some embodiments, training is based on a type of the characteristic of the user.
In some embodiments, the type of the characteristic of the user includes an occurrence of cardiac arrhythmia.
In certain embodiments, the computing system is further configured to provide a report, the report comprising the likelihood of the occurrence of cardiac arrhythmia.
In certain embodiments, the report comprises a graph over time of atrial fibrillation burden.
In certain embodiments, the report comprises indications for a presence of atrial fibrillation.
In certain embodiments, the report comprises at least a 14 day monitoring period.
In certain embodiments, the computing system is a server or a gateway.
In certain embodiments, the computing system is a smartphone.
In certain embodiments, the computing system communicates with the transmitter through a smartphone intermediary.
In certain embodiments, the wearable device is configured to collect a secondary signal and the hardware processor is configured to process the secondary signal through the first subset of layers of the neural network.
In certain embodiments, the wearable device further comprises an accelerometer configured to measure movement of the user, and wherein the secondary signal is accelerometer data.
In certain embodiments, the computing system is further configured to determine an atrial fibrillation burden, and the atrial fibrillation burden comprises an amount of time spent in atrial fibrillation during movement of the user.
In certain embodiments, the movement of the user comprises a first degree of movement and a second degree of movement.
In certain embodiments, the secondary signal is electrode contact quality data.
In certain embodiments, the electrodes and hardware processor are contained within a chest strap.
In certain embodiments, the electrodes and hardware processor are contained within a watch, configured to be worn on a human wrist.
In certain embodiments, the electrodes and hardware processor are contained within a wearable fitness band.
In certain embodiments, the arrhythmia comprises ventricular tachycardia.
In certain embodiments, the arrhythmia comprises supraventricular tachycardia.
In certain embodiments, the arrhythmia comprises ectopy.
In certain embodiments, the arrhythmia comprises ventricular fibrillation.
In certain embodiments, the arrhythmia comprises extended pauses.
In certain embodiments, the hardware processor is configured to be removed from the wearable device and modified while removed from the wearable device.
In certain embodiments, to quantize the output comprises rounding or truncating the values in the output.
In certain embodiments, the amount of quantization to the output is based on lossless compression performance.
In certain embodiments, the amount of quantization to the output is based on an efficiency on at least one of: processing power, storage, or network usage, and accuracy of the neural network.
In certain embodiments, the neural network is trained by applying quantization to the output of the first subset of layers of the neural network.
In certain embodiments, the neural network is trained by applying lossless compression to the output of the first subset of layers of the neural network.
In certain embodiments, the neural network is trained by applying quantization and lossless compression to the output of the first subset of layers of the neural network.
In certain embodiments, the neural network is trained without quantization and lossless compression to generate a first neural network, and the first neural network is trained by applying quantization and lossless compression to the output of the first subset of layers of the neural network to generate a second neural network.
Some embodiments include a wearable device for monitoring data, the wearable device comprising: a sensor configured to detect cardiac signals from a user; a hardware processor configured to process the detected cardiac signals through a first subset of layers of a neural network; and a transmitter, the transmitter configured to transmit the output of the first subset to a computing system, the computing system configured to infer a likelihood of an occurrence of cardiac arrhythmia by processing the output through a second subset of layers of the neural network.
Some embodiments include a computing system for estimating a likelihood of an occurrence of cardiac arrhythmia, the computing system comprising: one or more first hardware processors configured to: receive data from a wearable device, wherein the wearable device comprises a sensor configured to detect cardiac signals from a user, and one or more second hardware processors configured to process the detected cardiac signals through a first subset of layers of a neural network; process the received data through a second subset of layers of the neural network; and receive, from the output of the second subset of layers, an inference of a likelihood of an occurrence of cardiac arrhythmia.
Some embodiments include a method for monitoring data, the method comprising: detecting cardiac signals from a user; processing the detected cardiac signals through a first subset of layers of a neural network; and transmitting the output of the first subset to a computing system, the computing system inferring a likelihood of an occurrence of cardiac arrhythmia by processing the output through a second subset of layers of the neural network.
Some embodiments include a non-transitory computer storage medium storing computer-executable instructions that, when executed by a processor, cause the processor to perform the following method: detecting cardiac signals from a user; processing the detected cardiac signals through a first subset of layers of a neural network; and transmitting the output of the first subset to a computing system, the computing system inferring a likelihood of an occurrence of cardiac arrhythmia by processing the output through a second subset of layers of the neural network.
Some embodiments include a method for training a neural network to infer a likelihood of a characteristic of a user, the method comprising: training a first neural network to identify a first feature by processing first training data of a first time period through the first neural network; freezing weights of the first neural network; training a second neural network to identify a second feature by processing second training data of a second time period through the first and second neural network, wherein the second time period is longer than the first time period; unfreezing weights of the first neural network; and training the first and second neural network simultaneously to identify the second feature by processing third training data of a third time period through the first and second neural network, wherein the third time period is longer than the first time period.
In certain embodiments, the second training data is the third training data, and the second time period is the third time period.
In certain embodiments, training is based on available processing power of a wearable device.
In certain embodiments, training is based on available memory of a wearable device.
In certain embodiments, training is based on network availability between a wearable device and an external computing system.
In certain embodiments, training is based on a type of the characteristic of the user.
In certain embodiments, the type of the characteristic of the user includes an occurrence of cardiac arrhythmia.
Some embodiments include a system for training a neural network to infer a likelihood of a characteristic of a user, the system comprising: a wearable cardiac monitor device comprising: a watertight housing; a surface on the housing configured to be sealably engaged to a mammal; an adhesive on the surface configured to remain continuously affixed to the mammal for at least 7 days, without removal until completion of monitoring; at least two electrodes permanently disposed within the housing, positioned to detect continuous cardiac rhythm signals of the mammal while the surface is sealably engaged to the mammal; a hardware processor configured to process the detected cardiac rhythm signals through a first subset of layers of a neural network; and a transmitter, the transmitter configured to transmit the output of the first subset to a computing system, the computing system configured to infer a likelihood of an occurrence of cardiac arrhythmia by processing the output through a second subset of layers of the neural network, wherein the system is configured to train the neural network by: training a first neural network to identify a first feature by processing first training data of a first time period through the first neural network; freezing weights of the first neural network; training a second neural network to identify a second feature by processing second training data of a second time period through the first and second neural network, wherein the second time period is longer than the first time period; unfreezing weights of the first neural network; and training the first and second neural network simultaneously to identify the second feature by processing third training data of a third time period through the first and second neural network, wherein the third time period is longer than the first time period.
Some embodiments include a wearable device for monitoring bio-signal data of a user, the wearable device comprising: an adhesive assembly comprising a housing and a wing, the wing comprising an electrode configured to detect cardiac signals from a user; a hardware processor configured to process the detected cardiac signals through a first subset of layers of a neural network; and a transmitter, the transmitter configured to transmit the output of the first subset to a computing system, the computing system configured to infer a QT interval by processing the output through a second subset of layers of the neural network.
In certain embodiments, the computing system is further configured to determine an atrial fibrillation burden from the detected cardiac signals.
In certain embodiments, the atrial fibrillation burden comprises an amount of time spent in atrial fibrillation by the user during a period of time.
In certain embodiments, the atrial fibrillation burden comprises an amount of time spent in atrial fibrillation by the user during a sleep period and during a wake period.
In certain embodiments, the hardware processor is configured to process the detected cardiac signals through the first subset of layers of the neural network continuously in substantially real-time of detecting ECG signals.
In certain embodiments, the output of the first subset of layers of the neural network comprises an indication of an R peak.
In certain embodiments, the computing system is further configured to reconstruct the cardiac signals via the second subset of layers.
Some embodiments include a system for training a neural network to infer a likelihood of a characteristic of a user, the system comprising: a wearable device comprising: an assembly comprising an electrode configured to detect cardiac signals from a user; a hardware processor configured to process the detected cardiac signals through a first subset of layers of a neural network; and a transmitter, the transmitter configured to transmit the output of the first subset to a computing system, the computing system configured to infer a likelihood of an occurrence of cardiac arrhythmia by processing the output through a second subset of layers of the neural network, wherein the system is configured to train the neural network by: training a first neural network to identify a first feature by processing first training data of a first time period through the first neural network; freezing weights of the first neural network; training a second neural network to identify a second feature by processing second training data of a second time period through the first and second neural network, wherein the second time period is longer than the first time period; unfreezing weights of the first neural network; and training the first and second neural network simultaneously to identify the second feature by processing third training data of a third time period through the first and second neural network, wherein the third time period is longer than the first time period.
In certain embodiments, the output of the first subset of layers of the neural network is of a smaller dimensionality than the input of the first subset of layers of the neural network.
In certain embodiments, the hardware processor is configured to select the neural network from a plurality of neural networks based on a characteristic.
In certain embodiments, the characteristic comprises at least one of: a characteristic of the wearable device, a network characteristic between the wearable device and the computing system.
In certain embodiments, the hardware processor is further configured to compress the output of the first subset of layers of the neural network, wherein to transmit the output of the first subset to the computing system comprises transmitting the compressed output, wherein the computing system is configured to decompress the transmitted data; and wherein processing the output through the second subset of layers comprises processing the decompressed data.
In certain embodiments, the hardware processor is further configured to quantize the output of the first subset of layers of the neural network, wherein to transmit the output of the first subset to the computing system comprises transmitting the output.
In certain embodiments, the computing system infers the QT interval by reconstructing the ECG signal from the output of the second subset of layers of the neural network.
In certain embodiments, the computing system infers the QT interval based on an average QT interval from a window of encoded features that include a plurality of QT intervals.
Some embodiments include a wearable device for monitoring bio-signal data of a user, the wearable device comprising: an adhesive assembly comprising a housing and a wing, the wing comprising an electrode configured to detect cardiac signals from a user; a hardware processor configured to process the detected cardiac signals through a first subset of layers of a neural network; and a transmitter, the transmitter configured to transmit the output of the first subset to a computing system, the computing system configured to generate a template beat based on a plurality of beats over a period of time.
Some embodiments include a wearable device for monitoring bio-signal data of a user, the wearable device comprising: an assembly comprising an electrode configured to detect cardiac signals from a user; a hardware processor configured to process the detected cardiac signals through a first subset of layers of a neural network, the output of the first subset of layers of the neural network comprises RR peak intervals, wherein an RR peak interval comprises a duration between two consecutive R-peaks; and a transmitter, the transmitter configured to transmit the output of the first subset to a computing system, the computing system configured to infer a likelihood of an occurrence of cardiac arrhythmia by processing the RR peak intervals in the output of the first subset of layers of the neural network through a second subset of layers of the neural network.
In certain embodiments, first subset of layers of the neural network generates a sequence of RR peak intervals by extracting RR-interval sub-sequences using an overlapping sliding window and shifting the sliding window on the detected cardiac signals.
These and other aspects and embodiments of the invention are described in greater detail below, with reference to the drawing figures.
The following description is directed to a number of various embodiments. The described embodiments, however, may be implemented and/or varied in many different ways. For example, the described embodiments may be implemented in any suitable device, apparatus, or system to monitor any of a number of physiological parameters. For example, the following discussion focuses primarily on long-term, patch-based cardiac rhythm monitoring devices. In one alternative embodiment, a physiological monitoring device may be used, for example, for pulse oximetry and diagnosis of obstructive sleep apnea. The method of using a physiological monitoring device may also vary. In some cases, a device may be worn for one week or less, while in other cases, a device may be worn for at least seven days and/or for more than seven days, for example between fourteen days and twenty-one days or even longer.
Since abnormal heart rhythms or arrhythmias can often be due to other, less serious causes, a key challenge is to determine when any of these symptoms are due to an arrhythmia. Oftentimes, arrhythmias occur infrequently and/or episodically, making rapid and reliable diagnosis difficult. Currently, cardiac rhythm monitoring is primarily accomplished through the use of devices, such as Holter monitors, that use short-duration (less than 1 day) electrodes affixed to the chest. Wires connect the electrodes to a recording device, usually worn on a belt. The electrodes need daily changing and the wires are cumbersome. The devices also have limited memory and recording time. Wearing the device interferes with patient movement and often precludes performing certain activities while being monitored, such as bathing. Further, Holter monitors are capital equipment with limited availability, a situation that often leads to supply constraints and corresponding testing delays. These limitations severely hinder the diagnostic usefulness of the device, the compliance of patients using the device, and the likelihood of capturing all important information. Lack of compliance and the shortcomings of the devices often lead to the need for additional devices, follow-on monitoring, or other tests to make a correct diagnosis.
Current methods to correlate symptoms with the occurrence of arrhythmias, including the use of cardiac rhythm monitoring devices, such as Holter monitors and cardiac event recorders, are often not sufficient to allow an accurate diagnosis to be made. In fact, Holter monitors have been shown to not lead to a diagnosis up to 90% of the time (“Assessment of the Diagnostic Value of 24-Hour Ambulatory Electrocardiographic Monitoring”, by D E Ward et al. Biotelemetry Patient Monitoring, vol. 7, published in 1980).
Additionally, the medical treatment process to actually obtain a cardiac rhythm monitoring device and initiate monitoring is typically very complicated. There are usually numerous steps involved in ordering, tracking, monitoring, retrieving, and analyzing the data from such a monitoring device. In most cases, cardiac monitoring devices used today are ordered by a cardiologist or a cardiac electrophysiologist (EP), rather than the patient's primary care physician (PCP). This is of significance since the PCP is often the first physician to see the patient and determine that the patient's symptoms could be due to an arrhythmia. After the patient sees the PCP, the PCP will make an appointment for the patient to see a cardiologist or an EP. This appointment is usually several weeks from the initial visit with the PCP, which in itself leads to a delay in making a potential diagnosis as well as increases the likelihood that an arrhythmia episode will occur and go undiagnosed. When the patient finally sees the cardiologist or EP, a cardiac rhythm monitoring device will usually be ordered. The monitoring period can last 24 to 48 hours (Holter monitor) or up to a month (cardiac event monitor or mobile telemetry device). Once the monitoring has been completed, the patient typically must return the device to the clinic, which itself can be an inconvenience. After the data has been processed by the monitoring company or by a technician on-site at a hospital or office, a report will finally be sent to the cardiologist or EP for analysis. This complex process results in fewer patients receiving cardiac rhythm monitoring than would ideally receive it.
To address some of these issues with cardiac monitoring, the assignee of the present application developed various embodiments of a small, long-term, wearable, physiological monitoring device. One embodiment of the device is the Zio® Patch. Various embodiments are also described, for example, in U.S. Pat. Nos. 8,150,502, 8,160,682 8,244,335, 8,560,046, and 8,538,503, the full disclosures of which are hereby incorporated herein by reference. Generally, the physiological patch-based monitors described in the above references fit comfortably on a patient's chest and are designed to be worn for at least one week and typically two to three weeks. The monitors detect and record cardiac rhythm signal data continuously while the device is worn, and this cardiac rhythm data is then available for processing and analysis.
Referring to
Referring now to
Battery holder 150, according to various alternative embodiments, may hold two batteries (as in the illustrated embodiment), one battery, or more than two batteries. In other alternative embodiments, other power sources may be used. In the embodiment shown, battery holder 150 includes multiple retain tabs 153 for holding batteries 160 in holder 150. Additionally, battery holder 150 includes multiple feet 152 to establish correct spacing of batteries 160 from the surface of PCBA 120 and ensure proper contact with spring fingers 235 and 236. Spring fingers 235 and 236 are used in this embodiment rather than soldering batteries 160 to PCBA 120. Although soldering may be used in alternative embodiments, one advantage of spring fingers 235 and 236 is that they allow batteries 160 to be removed from PCBA 120 and holder 150 without damaging either of those components, thus allowing for multiple reuses of both Eliminating solder connections also simplifies and speeds up assembly and disassembly of monitoring device 100. In some embodiments, upper housing member 140 may act as a patient event trigger.
Referring now to the embodiments in
With reference now to the embodiments of
As illustrated in the embodiments of
With reference now to the embodiment of
Referring now to the embodiment of
With reference now to the embodiments of
Referring to
Referring now to the embodiments of
Referring now to
In a next step, referring to
The physiological monitors described above and elsewhere in the specification may further be combined with methods and systems of data processing and transmission that improve the collection of data from the monitor. Further, the methods and systems described below may improve the performance of the monitors by enabling timely transmission of clinical information while maintaining the high patient compliance and ease-of-use of the monitor described above. For example, the methods and systems of data processing and transmission described herein this section of elsewhere in the specification may serve to extend the battery life of the monitor, improve the accuracy of the monitor, and/or provide other improvements and advantages as described herein this section or elsewhere in the specification.
The systems and methods described in detail below, in reference to the embodiments of
In certain embodiments, a cardiac rhythm inference system may accept a plurality of R-R interval time series measured from devices of a given user 918, in addition to an individual R-R interval time series 902. In particular embodiments, a cardiac rhythm inference system 910 may accept additional sources of data, generally described as alternate sensor channels, in addition to R-R interval time series data, to enhance the accuracy and/or value of the inferred results.
Current wearable sensors, such as the iRhythm ZioPatch™ 904, and further described above in relation to
Once the feature extraction as described above is completed, various features 1008 may then be transmitted 1010 to a processing device/server 1012. The features 1008 (and alternate sensor channel data and/or features as described below) are transmitted 1010 at regular intervals to a processor 1012 that is not a physical part of the sensor 1002.
In some embodiments, the transmitted features 1014 are processed by the remote processor utilizing the data features 1014 to perform analysis via a rhythm inference system 1016 that analyzes and identifies segments/locations 1018 likely to include arrhythmia. For example, arrhythmia and ectopy types that may be identified could include: Pause, 2nd or 3rd degree AVB, Complete Heart Block, SVT, AF, VT, VF, Bigeminy, Trigeminy, and/or Ectopy. Confidence of determination may be included in the identification of rhythms.
The identified arrhythmia locations 1018 are then transmitted 1020 back to the sensor 1002. The transmission 1020 back to the sensor may be accomplished by any communication protocols/technology described herein this section or elsewhere in the specification, for example via Bluetooth. The sensor then reads the transmitted identified locations 1022 and accesses 1024 the areas of memory corresponding to the transmitted identified locations 1022 of the ECG. In some embodiments, the sensor applies additional analysis of the identified segments to further build confidence in the arrhythmia identification. This further rhythm confidence determination step 1026 allows for increasing positive predictivity prior to the power-hungry transmission step. In embodiments, if the confidence exceeds a defined threshold the data segment is transmitted. If the confidence exceeds a threshold as described above, the sensor 1002 may transmit the requested ECG segments 1028 to the processing device via any transmission means described herein this section or elsewhere in the specification.
The consumer device system 5000 without full ECG sensing advantageously enables arrhythmia analysis using consumer-available heart-rate sensors, thereby reducing the cost and increasing the availability of the device. Consequently, this may enable arrhythmia screening on a larger population, including via over-the-counter screening.
Some embodiments disclose a wearable device. The wearable device can comprise sensors for detecting bio-signals of a user, such as ECG signals. The wearable device can process the detected bio-signals through a first subset of layers of a neural network. The wearable device can take the output of a first subset of layers of a neural network, and transmit the output to a computing device (e.g., an external system such as a smart phone or a server) to further process the data through a second subset of layers of the same neural network in order to derive a characteristic of the user, such as an indication of past cardiac arrhythmia and/or predict a future onset of arrhythmia. In some embodiments, the computing device is a processor external to the wearable device or a processor within the wearable device. In certain embodiments, as described herein, at least some of the computation may occur on one more processors external to the wearable device and/or one or more processors within the wearable device.
In some embodiments, the output of the first subset of layers are an indication of R peak sequences. In other embodiments, the output of the first subset of layers are an indication of RR intervals. The wearable device can process the ECG signal through the first subset of layers of the neural network to receive R peak sequences from the output of the first subset of layers. The wearable device can transmit the R peak sequences to an external computing device. The external computing device can process the R peak sequences through the second subset of layers of the neural network, and receive as an output of the second subset of layers a derived characteristic of the user (such as the indication of past cardiac arrhythmia and/or predict a future onset of arrhythmia, burden of atrial fibrillation, etc).
There has been a lot of recent activity exploring the usage of wearable sensors to detect cardiac arrhythmias like atrial fibrillation (AFib). The wearable sensors used for such studies fall broadly into two categories. The first category of devices are electrocardiographic (ECG) monitoring devices. The second category of devices are photoplethysmography (PPG) based devices. When using PPG-based devices for AFib detection, the results have been mixed. For example, in one study, utilizing the heart rate and step count data from a PPG based device, a deep neural network based algorithm on a dataset where PPG data was obtained from a patient cohort immediately before and after cardioversion for AFib in a clinical setting resulted in decent results, but the same approach and algorithm had a more modest performance on a much broader ambulatory cohort of patients with persistent AFib. The reasons for the poor performance on the ambulatory cohort of patients could be numerous but the most influential factor is very likely the poor PPG signal quality for heart-rate estimation in uncontrolled settings. This raises the need to detect AFib more accurately using heart rate data derived from ECG signals recorded using a wearable cardiac monitor like the ECG monitoring devices.
AFib burden is the fraction of time that a patient spends in the AFib state. Recently, the notion of AFib burden has gained a lot of attention due to studies demonstrating the association of AFib burden and the risk of ischemic stroke in adults. Therefore cardiac monitoring solutions where one can quickly and accurately estimate the AFib burden of a patient can lead to meaningful medical interventions for patients who have been identified with having a higher risk for stroke.
For clinical analysis, a patient's ECG signal recorded using a cardiac monitoring device is typically segmented into episodes of varying durations and of different rhythm types. A normal, healthy patient will typically be in a state of a normal rhythm referred to as Normal Sinus Rhythm (NSR). Various heart conditions can manifest as patterns of irregular/abnormal heart beats known as cardiac arrhythmias which in turn translate into irregular/abnormal patterns in the ECG signal. There are various types of cardiac arrhythmias such as atrial fibrillation. A patient could switch back and forth between a normal rhythm and one/many of the different types of cardiac arrhythmias or could even be constantly in one of these abnormal rhythms like AFib. AFib burden is the fraction of time that a patient spends in a state of atrial fibrillation. Atrial flutter is another arrhythmia that is closely related to AFib and increases the risk for stroke. AFib and atrial flutter are at times difficult to discern from each other and are typically grouped together for burden calculations due to similar clinical significance. Therefore, for the purposes of this disclosure, embodiments will be described in reference to AFib, but it is understood that some embodiments can apply also (or only) to atrial flutter.
The QRS complex is a dominant feature of an ECG signal. The peak within the QRS complex is commonly referred to as the R-peak. Some embodiments detect R-peak signals from the ECG signal. Once R-peaks are detected, the instantaneous heart rate can be estimated as the inverse of the duration between two consecutive R-peaks (referred to as the RR-interval). A key signature of AFib episodes is high RR-interval variability.
The ECG signal recorded from a patient can be segmented into episodes of different rhythm types and then the AFib burden can be compute by calculating the fraction of time spent in the AFib state. However, if the computation is based only on the extracted sequence of R-peak locations (and not the whole ECG signal), estimating the AFib burden becomes a different algorithmic problem. A scenario where such an algorithm could be useful is when we might want to avoid excessive computations on the monitoring device itself (using the entire ECG signal) or when we might want to limit the amount of data that is transmitted from the monitoring device using wireless communications to computer servers where the AFib burden is calculated.
Described herein are embodiments that detect AFib reliably using heart rate data obtained from a wearable cardiac monitor. Some embodiments can also estimate the daily AFib burden of patients reliably.
In some embodiments, the algorithm (e.g., a neural network) can estimate AFib burden over shorter analysis windows (e.g., duration in the order of a half hour or one hour).
In some embodiments, the burden over a longer period of time (e.g., longer than the shorter analysis windows) can be determined by accumulating the burden predictions over the analysis windows. For example, the burden can be accumulated over non-overlapping analysis windows of half-hour duration. Given the R-peak sequence over an analysis window of half-hour, the RR-interval sequence within the analysis window is derived. This RR-interval sequence is then transformed into a sequence of RR-interval sub-sequences by extracting the RR-interval sub-sequences from a set of possibly overlapping sliding windows of duration w (contained with the analysis window) and shifted by an amount s. The RR-interval sub-sequence obtained from each sliding window is padded/truncated so that all sub-sequences have the same length M. For example, if there are Nw such sliding windows within the analysis window, the dimension for the temporal sequence is (Nw, M). The temporal sequence feeds into a neural network model for making burden predictions. For the purposes of explaining the concept, w was chosen to be 30 seconds, s chosen to be 25 seconds and M chosen to be 42. The portion of the neural network (e.g., a first subset of layers of the neural network) on the monitor can process the detected cardiac signals to generate the RR-interval data (and/or the RR-interval sub-sequences), and transmit the RR-interval data to a remote computing device. The remote computing device can process the RR-interval data (such as by processing through a second portion of the neural network (e.g., a second subset of layers of the neural network) to make inferences, such as a likelihood of arrythmia. In some embodiments, the neural network can be trained to make a determination on use of the wearable device, such as an indication that the user should wear the device longer due to a higher risk of a potential negative health event, or that the user is at low risk and can end their wear period earlier.
Advantageously, such segregated processing of the data can have many technical benefits. For example, such selective transmission of data that is partially processed can decrease power consumption for the wearable path. The wearable patch is not required to store the entire data processing algorithm (such as the entire neural network), but may only need to retrieve a subset of the neural network layers to process. Thus, the data processing on the wearable device can be much faster, require less computations, and use less battery via the processing. The analysis on the wearable patch side may not require full on-board rhythm analysis which can often times be very highly power consumptive, reducing battery life. Decreased battery consumption can prolong the use of the wearable device, such as the time period between device replacement, battery recharging, and the like. Moreover, the wearable device can have longer monitoring times to get a fuller picture of a patient's cardiac rhythms.
Another advantage for remote analysis based on RR-interval data may allow for greater sensitivity and accuracy than analysis on the path. Because of the memory, processing, and battery restrictions on the wearable patch, analysis on the wearable patch can be limited by these restrictions. Remote analysis can process the data through a wide variety of algorithms, even algorithms based on a decision tree of determinations and occurrences.
Moreover, the wearable patch can send a smaller dimensionality of data than the entire detected cardiac signal. Advantageously, less network throughput is required. The wearable patch can send sufficient data for remote data processing even when wireless network conditions may not be optimal. Moreover, because only a subset of the neural network need be uploaded to the wearable patch, the wearable patch can be updated with updated neural network computer-executable instructions or downloadable executable faster and under weaker network conditions, and can occur more frequently.
Furthermore, because of the lower battery and power requirements, a smaller CPU or a smaller battery can be used to result in a much smaller form factor for the wearable patch. In addition, the reduction of battery and power requirements for the data processing frees the battery and power budget for the wearable device, such that the wearable device can perform other critical tasks, such as running other critical software processes, or powering other hardware devices, such as more electrodes, other sensors such as accelerometers, or running the same hardware and software for a longer period of time.
The neural network encoding approach advantageously allows for very sophisticated algorithms to be run from data on a battery constrained device. One application of this would be to aggregate the encoded data from the device in real time, and run algorithms that will assess the overall risk of a subject developing a certain clinical outcome. As such, the system can inform the user of a wear period dynamically. For example, if after the wearable device aggregates a certain amount of data, the remote computing device may determine that the subject has very low risk for developing a certain clinical outcome. The system can inform the user to the wear period early. Conversely, if the computing device has determined that the user is at a high risk for a certain clinical outcome, the system can inform the user to wear the device longer.
Another technical advantage of having a first subset of layers of a neural network output the RR interval data to be sent for remote processing is that the algorithms for making inferences remotely can be updated without having to update the wearable patch. For example, an updated algorithm or neural network can be updated on the remote computing device via an update to the second subset of layers, whereas the same first subset of layers can be used on the wearable device. The technical advantage is that the second subset of layers can be selected based on a decision tree, updated or swapped with other algorithms, and the like without having to update the wearable patch, making the system more compatible with other algorithms.
The first layer 1902 is a temporally distributed feature extraction layer which extracts a 32-dimensional feature vector for each RR-interval sub-sequence obtained from the sliding windows. The output of this layer is a transformed sequence of dimension (Nw, 32). This transformed sequence then feeds into two Recurrent Neural Network (RNN) layers 1904, 1906 with Long Short Term Memory (LSTM) cells. The first RNN layer 1904 returns another transformed sequence of dimension (Nw, 32) while the second RNN layer 1906 returns a single output of dimension 32. This is followed by two Dense (fully connected) layers 1908, 1910 producing a scalar value representing the AFib burden for the analysis window.
At the start of
For the neural network, a loss function that can be used is the mean (over all samples) of the absolute difference between the burden prediction coming from the model and the true burden value:
Here, {circumflex over (b)}i is the burden prediction output by the model for the ith window in the dataset, bi is the true burden for that window and N is the total number of samples in the dataset.
In some embodiments, the parameters of the feature extraction network (e.g.,
The parameters of the feature extracting network thus obtained are then frozen and the resulting feature extracting network is plugged into the burden prediction model (
The feature extractor network is trained over a much larger and diverse set of ECG strips and directly learns features that are indicative of the presence/absence of AFib. When training the remaining layers of the burden prediction model, the number of parameters that have to be learned are reduced and therefore the search for the optimal parameters possibly happens faster. In contrast, if the entire network were to be trained at the same time, the number of parameters that have to be learned simultaneously is larger and the model is exposed to a less diverse set of ECG strips. This increases the risk for over-fitting and possibly explains the wider gap between the validation loss and the training loss.
Some embodiments disclose a wearable device that can process the detected bio-signals through an encoder that includes a first subset of layers of a neural network.
In some embodiments, the first subset and the second subset of layers are within one neural network. The neural network can be designed such that the output of a first subset of layers can output data at a smaller dimensionality than the input to the neural network, and the output of the second subset of layers can be designed to provide an indication of a user characteristic, such as a past or future prediction of AFib.
In some embodiments, the output of the first subset of layers can be a smaller dimensionality than the input to the neural network. As such, instead of transmitting the entire ECG signal (e.g., the input to the neural network) from the wearable device to the external computing device, the wearable device can transmit a smaller amount of data to the external computing device, such as the 128 bps output data 2234 of the first subset of layers instead of the full 2400 bps ECG signal 2232. Advantageously, less network throughput is required to derive the indication of past cardiac arrhythmia and/or predict a future onset of arrhythmia.
Moreover, instead of processing the ECG signal on the wearable device through all layers of the neural network in order to derive the indication of past cardiac arrhythmia and/or predict a future onset of arrhythmia, the wearable device can process the ECG signal through only a first subset of the layers (such as through an encoder) of the neural network via the ECG encoder 2230, and transmit the output of the first subset to an external device 2228 that processes the second subset of layers (such as through a decoder or classifier 2238).
Moreover, the wearable device 2246 can be smaller in size due to a smaller battery, processor, and other electronic devices required to process only a subset of layers of the neural network. The wearable device can have more resources to perform other tasks. For example, in one scenario, the wearable device 2242 may have enough computational power and battery to process the ECG signal internally and identify AFib for 5 days. However if the wearable device 2246 could compute the first subset of layers of the neural network on the wearable device 2246 and the external computing device 2250 process the second subset, the system as a whole may be able to identify both AFib and atrial flutter over the span of 20 days. Some embodiments disclosed herein can reduce network throughput, reduce computational requirements, and/or memory storage of the wearable device. Advantageously, the wearable device can preserve battery life by using less of the processor.
Certain disclosed embodiments herein improve on memory requirements of the wearable device. If the wearable device is to process a first subset of layers of the neural network and the external computing system the second subset, the wearable device has to store less data (e.g., software executable instructions for the first subset of layers and not the entire neural network). Thus, the electronic files are much smaller in size. Advantageously, the wearable device not only has less memory requirements, but the neural network can also be loaded and processed faster than the full neural network. Moreover, updating the software embedded within the wearable devices can occur much faster, under weaker network connection conditions, and can be programmed to occur more frequently. Furthermore, more neural networks can be stored in the wearable device. For example, instead of a single full neural network being stored in memory, the wearable patch can store the first subset of layers for 5 neural networks in local memory.
In some embodiments, because the purpose of the external computing device is not to reconstruct the ECG signal but rather to derive some user characteristic (e.g., predict rhythm classifications such as AFib), the data that is transmitted from the wearable device does not have to be sufficient to recover the full fidelity of the ECG signal. Thus, the neural network can be trained to generate an output in one of its layers that is a smaller dimensionality than the ECG signal input, and transmit much less to the external computing system to perform the other layers of the neural network.
Some embodiments improve on security of health data. For example, if the entire ECG signal, R peaks, RR intervals, or a final determination of the likelihood of AFib was transmitted from the wearable device to an external computing system, a third party may intercept such data and discern sensitive health data of a user. Instead, some embodiments disclosed herein transmit output of an intermediary layer of the neural network (such as the output of the encoder) to be processed by subsequent layers externally (such as the decoder). The transmitted data can be output of a layer in a neural network, which inherently provides encryption of data for data transmission. Thus, even if a third party were to intercept such data, they would not be able to decode the data, nor reverse engineer the original input of the neural network.
In some embodiments, the first subset of layers can include less computationally heavy layers whereas the second subset of layers can include more computationally heavy layers. Advantageously, the wearable device can process the less computationally heavy layers, and the external computing systems that are agnostic to the processing of the wearable device can process the more computationally heavy layers (such as in servers with much larger processing power and memory capacity).
In some embodiments, the wearable patch can perform preprocessing on the detected cardiac signals before processing the data through the first subset of layers of the neural network. For example, the wearable patch can perform preprocessing such as downsampling, normalizing, digital filtering, and/or the like. Moreover, the wearable patch can perform more complex preprocessing, such as a discrete wavelet transform, continuous wavelet transform, discrete Fourier transform and discrete cosine transform. These transforms can be beneficial in lossy compression schemes because the transformations transform the data in a way that results in a lot of values in the data being very close to zero. An encoding can then be created to simply store the values with the highest amplitude, which would limit error when reconstructing the signal.
The wearable patch may apply a discrete wavelet transform or a discrete cosine transform, and simply apply algorithms to make inferences on the detected cardiac data. However, such approaches may fail to capture more subtle features that are critical for the end application, such as ECG rhythm classification, because higher amplitude features are favored. In some embodiments, the system can train a neural network encoder on this transformed set of data (e.g., cardiac data that has been preprocessed) in order to more intelligently encode the data needed for the end application. Advantageously, this may be beneficial for some applications, because a transform may already be performing certain actions to the signal needed for the end application, which could lead to a more powerful or simpler neural network encoder design that had fewer parameters compared to one that works off the raw signal.
In some embodiments, the neural network can be trained and/or designed to transmit an optimal data dimensionality from the wearable device to the external computing system.
The neural network can be trained and/or designed based on one or more factors, such as available processing power and/or memory of the wearable device (for the purposes of the disclosure, the neural networks will be described as being trained, but the features can be applied for designing or processing data through the neural network, and vice versa). For example, if the wearable device has less processing power, the neural network can be trained to perform less computation and/or perform processing through less layers of the neural network on the wearable device, and process more on the external computing system side. The patch 2281 can apply the third neural network 2288 that includes fewer computations and/or layers of the neural network.
In some embodiments, the neural network can be trained according to network availability between the wearable device and the computing system. For example, the neural network can be trained to process more layers and/or transmit a smaller data dimensionality from the wearable device to the external computing system when the network throughput is lower. The patch 2281 can apply the second neural network 2286 that includes a smaller data dimensionality being transferred to the server 2282 for when the network connection is weak (or below a threshold).
In some embodiments, the neural network can be trained according to available battery life of the wearable device. For example, the neural network can be trained to process less layers on the wearable device when the battery life is lower. The patch 2281 can apply the third neural network 2288 that includes fewer computations and/or layers of the neural network.
In some embodiments, the neural network can be trained according to the desired outcome. For example, the patch 2281 can apply the first neural network 2284 that includes more outputs of the neural network, such as more characteristics of the user. For example, if the patient is in critical care or has an indication of AFib, the patch 2281 can apply the first neural network 2284 and process more layers and nodes through the first subset of layers 2284A, such that the server 2282 can output more information via the outputs of the second subset of layers 2284B.
In some embodiments, the software in the patch 2281 can include instructions for a particular neural network designed (and/or trained) for a particular application. For example, a neural network can be selected for a patch 2281 with certain technical constraints (e.g., memory or processor), and to serve a particular purpose (e.g., predict AFib), whereas another neural network can be selected for a different patch with different characteristics and for different purposes. For example, an accurate detection of AFib can require more data from the patch than another desired purpose. Thus, a patch that is to detect AFib may have software that computes more layers than another patch.
In some embodiments, the software in the patch 2281 can be designed (and/or trained) based on performance metrics. For example, the software can select a neural network that is designed to produce a certain accuracy in detection and/or a certain false alarm rate.
In some embodiments, the software in the patch 2281 can include a plurality of neural networks. The patch 2281 can select a particular neural network out of the plurality of networks. For example, the selection can be based on a neural network designed for low battery power or network connectivity (e.g., switching to a neural network that processes less on the patch or transmits less data through the network).
In some embodiments, the neural network can be trained to recreate the original input signal to the neural network, such as the ECG signal, RR interval information, R peak information, a metric derived from the ECG signal, accelerometer data, impedance, temperature, audio (e.g., snoring), ambient light, and/or the like. The patch 2281 can transmit data of a smaller data dimension to server 2282 for the server 2282 to recreate the original input signal, or a derivative thereof, such as the original input signal sampled at a lower frequency, lower quality signal, signal with a certain threshold for reconstruction error, and/or the like.
In some embodiments, the neural network can be trained according to the current activity of the user.
Training of models, such as artificial intelligence models is necessarily rooted in computer technology, and improves on models by using training data to train such models and thereafter applying the models to a new set of user data. Such training involves complex processing that typically requires a lot of processor computing and extended periods of time with large training data sets, which are typically performed by massive server systems. Training of models can require logistic regression or forward/backward propagating of training data that can include input data and expected output values that are used to adjust parameters of the models. Such training is the framework of machine learning algorithms that enable the models to be applied to new data (such as new biometric data) and make predictions that the model was trained for based on the weights or scores that were adjusted during training. Such training reduces false positives and increases the performance of detection of AFib.
In some embodiments, the wearable device can store a plurality of neural networks and can apply a neural network based on one or more characteristics, such as characteristics of the wearable device, network, current activity of the user, etc. For example, the wearable device can process a first neural network if the battery life is low, or a second neural network if the network throughput is high.
In some embodiments, the wearable device can process the ECG signal continuously through the first subset of layers of the neural network as the wearable device detects the ECG signal in real time. The wearable device can transmit the output of the first subset of layers continuously to the external computing device, and the external computing device can process the received output through the second subset of layers of the neural network in order to derive a characteristic of the user (e.g., cardiac arrhythmia) in substantially real-time. Advantageously, the external computing device can identify cardiac arrhythmia in substantial real-time of occurring with the user while reducing network throughput, memory requirements, and processing power requirements. Moreover, more powerful algorithms and neural networks, which would not have been able to be performed on the wearable device itself due to device restrictions nor completely on external computing systems due to input requirements, are now feasible.
In some embodiments, the neural network can include a first neural network and a second neural network. The first neural network (e.g., a temporally distributed feature extraction model) can receive as inputs one or more types of data, such as the ECG signal of a user, R peak data, RR interval sub-sequences (e.g., RR intervals in 30 second sliding windows), encoded features, and/or the like as further described herein. The first neural network can process the inputted RR interval sub-sequences and generate Atrial Fibrillation (AF) features for each sliding window. The output of the first neural network can be fed into the second neural network including recurrent layers with Long Short Term Memory (LSTM) cells. The LSTM cells can process the AF features of the current sliding window and past sliding windows to process the data using a transfer learning approach, where over the course of multiple sliding windows, the LSTM can advantageously predict an indication of a cardiac arrhythmia that takes into account data longer than the 30 second window.
In some embodiments, the first neural network and the second neural network is trained in stages. The first neural network can be trained first. Training data of 30 second intervals can be fed into the first neural network, and the weights can be adjusted based on the expected output of the first neural network. After the first neural network is trained, the weights of the first neural network can be frozen, and the second neural network can be trained. The second neural network can be trained based on longer intervals of data that are fed into the first neural network in 30 second windows, and the outputs are fed into the second neural network with LSTM cells. The second neural network can make predictions of AFib over the longer data sets, and the predicted outputs can be used to adjust the weights of the second neural network. Once the second neural network is trained, the weights of the first neural networks can be unfrozen, and both the first and second neural networks can be trained simultaneously using further training data.
As wearable bio-signal processing applications grow, there is an increasing need to improve the sophistication and utility of these applications. A common scenario is to have a small, battery-powered wearable, with an array of sensors measuring bio-signals processed and, optionally, transmitted in real-time or near real-time. Since device size will affect comfort, which in turn influences compliance and thus usefulness, it is advantageous to have as small of a device as possible. This introduces several constraints to the system—mainly battery life and processing capability—which in turn can negatively affect user experience by requiring the user to charge the battery or resulting in lower quality analytics and lower compliance. These constraints typically limit the sophistication of processing that occurs on the device, so an option utilized by many applications is to offload processing to systems with fewer constraints, such as smartphones, cloud servers or base stations.
Within this paradigm, a trade-off exists between the amount and type of data offloaded for additional processing. Ideally, the full-fidelity, raw bio-signals are offloaded in real-time to maximize processing sophistication on the lesser constrained part of the system. Unfortunately, within the limits of current technology, this is typically infeasible due to the battery cost and technical limitations of transmitting full-fidelity signals in real-time or even timely manner. A way to overcome this limitation is to send some smaller representation of the signal, thus minimizing power requirements and maximizing the time between battery charging or replacement, or the potential monitoring duration of a device if powered by a single battery charge.
There exist many strategies for creating this alternative representation. Depending on the application, custom-designed algorithms can be used to select features uploaded for further processing. An example of this strategy is a Mobile Cardiac Telemetry (MCT) device, or a wearable activity tracker capable of detecting and uploading the location of heart beats derived by algorithms running on the device, which could then be further analyzed to detect heart arrhythmias by more sophisticated algorithms on a cloud server. Another example is a wearable device that uses accelerometry to analyze gait, assess activity levels, and the risk of falls by uploading the results of the on-device step counting algorithm. The limitation with this set of approaches is that the selected feature may not be optimal for the end application, and the device-side algorithms may also be more computationally burdensome to compute than needed.
Another common approach would be to compress the raw bio-signal data in a way that allows reconstruction of the signal. Commonly used techniques include lossless and lossy compression schemes. Lossless compression, while allowing for optimal processing on cloud-based servers, does not typically provide a high enough compression ratio to reduce the data transmission burden sufficiently to be viable. Lossy compression techniques, such as wavelet-based compression, can achieve a high level of compression relative to the amount of error introduced during reconstruction. While this strategy may work well for certain applications, there is no guarantee that the reconstructed signal will keep the necessary information for the end application, since their objective is only to minimize signal reconstruction error. This type of objective is driven primarily by signal features with a high amplitude, and may ignore or distort features with small amplitude characteristics. Depending on the application, signal features that have relatively small amplitude may be critical to the end objective, such as with the subtle P-waves in an ECG associated with atrial depolarization, critical to detected rhythms such as atrial fibrillation and complete heart block.
System and methods disclosed herein achieves an optimal balance for all elements in a system: device processing burden, system transmission burden, and end application utility. This is accomplished utilizing neural network encoding, which can be used to generate a scheme that compresses raw bio-signal data in a computational friendly manner, preserving information needed for a specific end application. A neural network can encode a signal into a compressed format, and then reconstruct the signal. More generically, a neural network architecture can be built into encoder and decoder sections.
For this application, the encoder section would be responsible for compressing the raw bio-signals, would run on the target device, and would result in an output that has a smaller dimensionality than the input.
The decoder section would be responsible for producing predictions for a target application, starting from the encoded layer of the neural network, and would be employed elsewhere than the target device, for example, on a smartphone, cloud server, or communication hub/gateway. The encoder and decoder portions are trained as one end-to-end neural network, this would effectively create an optimal encoder and a decoder simultaneously because the encoder and decoder sections are being optimized together for the same objective. This method maximizes the flexibility of the system design, which can lead to the most optimal implementation. For example, the encoder section can be designed to target a specific computational complexity and compression, and the neural network output can be selected to be exactly what is needed for the end application. This technique is ideal for any real-time and near real-time signal processing applications that require high computational complexity and have a mechanism to offload processing.
Devices that utilize electrocardiogram (ECG), photoplethysmogram (PPG) or audio signals to detect both electrical and structural heart conditions in real- or near-real time face challenges outlined above. Certain heart arrhythmias present themselves in subtle ways, for example, in low-amplitude P-wave patterns in ECG recordings, often requiring a high level of sophistication and sensitivity in detection algorithms. To maximize clinical utility, rhythms may be categorized in up to fifteen different classes including noise, which not only rely on beat-to-beat heart rate patterns but also the differences in morphology that can often be elusive, especially in single-lead ECG applications. Existing devices may simply offload the entire raw signal, necessitating frequent charging or battery replacement, or use compression techniques to offload processing, or detect commonly understood features of the ECG signal on the device, and upload those to a separate system for further processing. The features may include the location of ECG morphological features such as QRS complexes, P waves, etc. Due to the limited computation power and battery life of these devices, algorithms will have limited accuracy in their ability to detect these morphological features. Neural network encoding can be employed to transmit a compressed representation of the ECG signal. This representation can be optimized for the specific end application, such as identifying specific cardiac arrhythmias, identifying ECG morphological features such as QRS complexes, classifying beat types, determining heart rate, etc.
In an example implementation of this strategy for real- or near real-time arrhythmia detection from ECG recordings, a neural network could first be trained using a set of 30 s ECG strips, sampled at 200 Hz, for example, with 14 distinct rhythm labels for each sample. As a preprocessing step, the 200 Hz signal will be down sampled by a factor of 3 using a moving average filter, and then conditioned using an IIR high pass filter with a 2 Hz cutoff. This input is also scaled to have unit variance. This will leave information in the range of ˜2-33 Hz, which will contain most of the ECG morphological information. This makes the input dimension of the signal into the neural network 2000×1. As mentioned above, the goal of the first section of the Neural Network is to compress the signal, so it will need to reduce the dimension of the input signal.
In an example embodiment, the encoding section of the neural network would have a sequence of convolutions and pooling layers, where each pooling layer reduces the temporal dimension by a factor of 2. With a sequence of convolution and pooling layers that repeats 3 times, this would result in a temporal dimension reduced by a factor of 8. Also in this example embodiment, the final convolution layer of the encoder section would have 2 filters, which will make the output dimension 250×2 and is referred to as the encoded output.
The next layers of the network employ a strategy to return the temporal dimension size back to its original size at the network input. This could be accomplished using several transposed convolution layers (sometimes referred to as deconvolution layers). The layers of this network up to this point can, in one embodiment, be pretrained to predict the original input signal. In one embodiment, the remaining layers consist of residual convolutional filter blocks. In this example, 12 sequential blocks were used, with each block containing 2 convolutional layers, with a residual connection from the input to output. These blocks also reduce the temporal dimension by a factor of 2 every other block. After the last of these blocks, a time-distributed dense layer is evaluated at each temporal point to predict a unique rhythm class. The above example describes one embodiment of a framework for training an algorithm to encode ECG information in a way that preserves diagnostic information in a compressed format.
In some embodiments, the encoding process can be implemented to perpetually generate ECG features. Using the above example neural network, a 6000-sample length ECG strip will create 250 examples of a feature vector with two dimensions. This can be thought of as every 24 individual ECG samples resulting in two encoded features. Since the nature of this processing is causal, these features can be created perpetually, without any concept of 30 s ECG segments. These features can be scaled to be stored in a compact integer representation, and lossless compression can be applied to further reduce the features memory footprint. With a continuous stream of encoded features, a server-side algorithm may employ a number of different strategies to detect events of interest using the encoded features.
In one embodiment for detecting segments that contain an arrhythmia (such as CHB, VT, AFIB/AFL, SVT, AVB etc), the original multiclass algorithm used to train the ECG encoding can be evaluated using 30-second contexts of encoded features that are generated on the patch. This algorithm can be evaluated on a rolling window of 30-second contexts, with or without overlap. Segments that have a high probability of containing an arrhythmia can be used to determine if an event of interest is present.
In one embodiment, the encoding section of the neural network may use a combination of convolutional, pooling and recurrent layers such as LSTM to reduce the dimensionality of the signal.
In one embodiment for detecting VT events, a neural network can be trained using the encoded features to predict sequences of VT in ECG segments that are about 1 second in duration. The benefit of this is that differentiation between more or less severe segments can be made for determining which events are of more interest. For example, longer segments could be prioritized over shorter ones. This algorithm could be used to determine the burden of VT episodes that meet a more specific length criterion. Traditional approaches to VT detection—particularly on a battery-constrained embedded device—relies on beat patterns that exhibit sudden increase in rate.
The reliance on beat detection, for example, the widely used Pan-Tompkins algorithm, whose performance is often poor on wider QRS beats, inevitably limits the ability to reliably discern beat patterns in arrhythmia such as VT. Even when full ECG is present and morphology information can be studied via signal processing techniques, the computational burden is high on a battery-operated device, leading to devices requiring charging once or more times daily and/or battery replacement on both the sensor and the gateway or mobile phone unit. For example, many current Mobile Cardiac Telemetry (MCT) modalities suffer from this requirement, which transfers its burden upon the patient, therefore contributing to lower compliance and lower analyzable time and clinical value from the diagnostic device.
In one embodiment for evaluating AF burden, the original neural network trained to create the ECG encoding can be evaluated over 30-second contexts to determine if the segment contains Atrial Fibrillation (AFIB) or Atrial Flutter (AFL), and the summation of these times can be used to calculate burden. In addition for Atrial Flutter, existing modalities often struggle with the differentiation of AFL from other regular rhythms such as Normal Sinus, since the irregularly irregular beat pattern characteristic of Atrial Fibrillation is not present. This requires closer examination of the signal between beats, which the encoded features allow. Of course, full ECG allows for this as well, but would require more computational power to process the information, which often takes the form of frequency domain analysis and in turn also leads to a less patient-friendly device with charging or battery replacements as discussed with in the MCTs embodiments above.
In another embodiment for evaluating AF burden, the encoded features can be fed into a recurrent neural network over a larger context, for example 30 minutes, to predict AF burden in the same manner as described above.
In another embodiment for characterizing VT, the encoded features can be fed into a network over a larger context, for example 30 minutes, to predict the total duration of VT and/or the number of discrete VT episodes that are present.
In one embodiment for determining heart rate, a neural network could be trained to predict the number of heart beats contained in a segment of time, for example, 3 seconds, using the encoded features. This neural network can be used to predict the number of beats in a segment of time over a sliding window, which can then be used to estimate heart rate at various times. This heart rate information can be used for further refinement or prioritization of events of interests that are detected using other algorithms. A similar strategy would enable the estimation of heart rate variability in lieu of or in addition to heart rate.
In one embodiment for determining ectopic beats counts, a neural network could be trained to predict the number of ectopic beats contained in a segment of time, for example, 3 seconds, using the encoded features. This neural network can be used to estimate the total number of ectopic beats over a window of time, for example, in a 1-, 12- or 24-hour period. Alternatively, combined with the heart beat embodiment described above, this embodiment could be used to estimate the ratio of ectopic to normal beats, for example, expressed as a percentage over a 1-, 12- or 24-hour period. This embodiment, described agnostically above, could be applied to either ventricular or supraventricular ectopic beats, and/or to couplets and triplets of each.
In one embodiment, R-peak locations may be approximated from the reconstructed time series from the encoded features. These R-peak locations could, on their own, be used to calculate heart rate, augment the accuracy of heart rate estimation from an alternate method, or to detect cardiac Pause events defined as a clinically significant gap in time between two ventricular contractions, for example, greater than three seconds. Like heart rates, this information can be used to further filter or prioritize events of interests whose ECG is to be transmitted and reported. In another embodiment, the reconstructed signal itself can be viewed along with portions of full ECG to provide more context, for example, whether low, high, or irregular heart rate continues from the end of the ECG segment. This contextual information can aid in the process of manually requesting more full resolution ECG from the patch based on visual inspection, leading to an overall higher diagnostic acuity backed by human quality assurance.
In an alternate embodiment, heart rates based on these R-peak locations could be plotted alongside the selected ECG strips in a clinical report in a manner that provides greater temporal context for the event shown in the brief (e.g., 8- or 16-second strip). The heart rates could be plotted as either instantaneous rates (e.g., based on the interval between two R-peaks), or as a heart rate trend over time with each data point derived from multiple R-peaks. An alternative embodiment could plot the average, max and min heart rates trends simultaneously to provide even greater clinical context.
In some embodiments, a wearable device that utilizes PPG and accelerometry can be used to detect Atrial Fibrillation (AFIB) episodes, and to estimate AFIB burden levels. Sensors in this configuration very commonly suffer from degraded signal quality due to environmental factors, such as being worn improperly, motion of the device, or poor physiological conditions. For this reason, it is advantageous to utilize the full fidelity raw sensor readings in order to detect AFIB or estimate AFIB burden, since the noise can be understood and prevent algorithms from predicting false positives.
Existing strategies may detect heart rate intervals on the device, and use this information to infer AFIB episodes. Signal quality metrics may be separately computed and uploaded. This strategy will suffer when periods of poor signal quality create false heart rate interval readings. Using the strategy outlined above, a neural network could be developed to predict AFIB episodes or AFIB burden from the raw PPG/accelerometer signals, which also encodes the signal in a compressed representation. This network can learn to encode the information in a way that is least prone to false predictions due to poor signal quality. The encoding can be run on the device, and the encoded data can be uploaded so that a decoding section would be evaluated on more powerful servers. In addition to identifying AFIB episodes and AFIB burden, encoded sensor data from a wearable PPG device could be used to characterize pulse rate or detect other heart arrhythmias, such as ventricular tachycardia, pause, atrioventricular block etc. They can also be used to detect health conditions such as diabetes, hypertension, depression, congestive heart failure, sleep apnea etc.
In another embodiment, encoded features can be optimized to describe waveform components of ECG beats in addition to R peaks, e.g. P-waves, T-waves and/or segments between points in a waveform. A neural network can be trained on the encoded features to estimate PR intervals, whose patterns can discern between subtle categorization of AV Block (1st degree, 2nd degree Mobitz I I.e. Wenckebach, 2nd degree Mobitz II) or characterize Wolff-Parkinson-White syndrome along with inference of QRS width. Some of these less life-threatening, asymptomatic arrhythmias may be desirable to be transmitted, especially if the device does not record and store all signal continuously like event recorders and ILRs or some MCTs where not all of the signal is fully analyzed.
In a similar manner, a neural network can be trained on the encoded features to estimate QT intervals, which can uncover clinically significant findings such as Long QT Syndrome, which may be monitored over the course of the wear time. For example, this QT measurement approach could be used for drug titration, where a patient would adjust drug dosage to determine the optimal mix of drug efficacy and safety on an individualized basis. A neural network can also be trained to detect changes in ST segments, which can be monitored to look for ST elevation or depression which may be warning signs for myocardial infarction.
In another embodiment, the encoding method can be dynamically adjusted and adapted as the system receives and learns more about the characteristics of the signal. It can also be swapped with a different scheme if the target rhythm changes for a specific patient. For instance, instead of a generalized method of detecting arrhythmia types, for certain neurology applications like post-stroke monitoring, the primary focus may be to detect AF, and regardless of heart rate or duration of the episode. A pair of encoding and decoding networks pretrained and optimized for high sensitivity of AF may be used in this case. These different encoders can be learned offline and updated over the air to the firmware when change is necessary, or pre-programmed as an option on the embedded device to be activated when requested. Alternate embodiments might implement algorithms optimized for either sensitivity or specificity performance, in a similar manner.
In certain embodiments, the input signal may include channels from accelerometer and/or gyroscope axes, which can often take up a lot of space due to the number of axes multiplied by the required sampling rate (e.g. 20 Hz to enable inference of step counts). The features in 3-axis accelerometer and/or 3-axis gyroscope signal can be reduced to a smaller dimensionality, which may contain valuable information not just limited to pre-defined physical metrics like magnitude. In fact, characteristics that can only be obtained via higher frequency sampling could be encoded to enable finer distinction between activities. Encoded accelerometer and/or gyroscope features on their own can be used to determine sleep stages and activity levels, step counts, orientation, activity type, etc. Encoded accelerometer and/or gyroscope features on their own, or features from these signals encoded together with ECG, can be used to further differentiate between signal generated by the physiological events such as arrhythmia versus that of motion artifact. The same data is also helpful as one input (trended activity level) to evaluating the health of heart failure patients, for example, in the form of an ambulatory monitor of decompensation events after hospital discharge.
In other embodiments, impedance information, or some other measurement indicative of skin contact such as galvanic skin response may be encoded along with the ECG or independently. A neural network can be trained to detect areas of leads off, and in conjunction with ECG features, be used to filter out segments of unreliable signal. Since the same impedance values can mean different levels of signal quality on different patients and conditions, a simple state-machine type of algorithm on impedance values alone may result in leads-on conditions when signal is actually non-physiological, or on the converse, leads off detected when the signal is actually ECG and therefore analyzable. The former is particularly an issue for ambulatory devices that are prone to noise which can sometimes mimic arrhythmia and therefore result in false positive transmissions, though some of it can be mitigated through hardware design and flexible materials such as on a patch form factor. Decoder algorithms that use encoded features of ECG, together with raw or encoded features of secondary signals such as impedance or accelerometer can further eliminate these false positives, while also ensuring that real ECG signal is not lost due to poor impedance.
In certain embodiments, suspected arrhythmia detected using the encoded features may benefit from further analysis using the full-resolution ECG on the original device. The power savings enabled by an encoder implementation would allow a decoder-based algorithm to request either transmission or on-board analysis of portions of full-resolution ECG stored on the device. A separate algorithm, which may be derived from convolutional neural networks trained on labeled full-resolution ECG, running on restricted regions of the original ECG would be computationally feasible.
In certain embodiments, encoded features may be used to learn and predict arrhythmia such as Atrial Fibrillation or other health conditions that may occur in the near future, enabling early intervention.
In certain embodiments, the processing, either the encoding or the subsequent layers that use the encoded features (decoding), may be done on the intermediate device transmitted prior to long-range connection such as cell or satellite, such as a smartphone or a gateway device. In certain use cases, for example, where raw signal does not need to be written to device memory, which is often an heavy part of battery consumption in these limited power modalities, both encoding and decoding can occur on the device itself, such as a patch, smartwatch, or other wearables capable of continuously monitoring ECG or other signals, and only the encoded signal written. This approach could be useful in a scenario where storage space is limited, but algorithms may need to run on data stored in memory (e.g., data for ECG that occurred in the past).
In certain embodiments, the technique may be applied to other surface or transcutaneous bio-signals other than ECG, such as PPG from the wrist, ear lobe or chest. Wearable devices, often consumer-grade, feature PPG signal capture to enable heart rate trending and in some cases, screening for Atrial Fibrillation. These health insight capabilities are often limited to detection of highly limited duration, e.g. 30 seconds, and require relatively high-power optical sensing, e.g. with green light to reliably capture waveforms through various skin types and motion. The entirety of the PPG cannot be stored or transmitted for more rich contextual analysis of anything beyond simple beat detection in case PPG wave morphology contains signatures unique to arrhythmic blood flow, or to aggregate into more long-term and clinically useful metrics such as AF burden.
In some embodiments, PPG and/or ECG waveforms are encoded in order to infer blood pressure and other cardiac metrics such as blood perfusion, blood volume, cardiac output, ejection fraction, valve function and/or health, etc., where the traditionally computed beat-to-beat or even fiducial point intervals may not be the most useful features. Although certain embodiments are described with PPG, it is understood that ECG can also be used where applicable, and vice versa.
In certain embodiments, the technique may be applied to even more data heavy signal such as EEG. Wearable applications employing EEGs are often limited to laboratory settings due to the number of channels and bulk of devices. Encoded features trained of EEG could enable offloading of high-computational power decoder algorithms to a server and enable mobility of devices that for example, translate brain activity into communication.
In some embodiments, the neural network encoding may be implemented in dedicated hardware, such as an FPGA IC to further reduce battery consumption on the target device. The neural network encoder may be further optimized for an embedded application by utilizing integer math or binary operations.
In some embodiments, image or video streams that result in detection of markers or objects or physiological measurements can use neural network encoding to offload processing to more powerful systems. Example applications would be
object detection in vehicles, security surveillance systems
emotional response from facial video
physiological measurements such as heart rate, breathing based on video streams of face or chest
detection of seizures
detection of falls
augmented reality
infant monitoring of notable events (crying, breathing issues)
In some embodiments, audio data may be encoded for the purpose of identifying speech events or translating speech in real-time, respiration monitoring, diagnosis of respiratory illnesses, detection of snoring or apnea.
In some embodiments, sonography data may be encoded for the purpose for identifying contraction during pregnancy, detecting and characterizing fetal heart beats, identifying anomalous physiology such as tumors, strokes, blocked arteries, infection, etc.
In some embodiments, the systems, tools and methods of using same described above enable interactivity and data collection performed by a computing system 13000.
In some embodiments, the computing system 13000 includes one or more computing devices, for example, a server, a laptop computer, a mobile device (for example, smart phone, smart watch, tablet, personal digital assistant), a kiosk, automobile console, or a media player, for example. In one embodiment, the computing device 13000 includes one or more central processing units (CPUs) 13105, which may each include a conventional or proprietary microprocessor. The computing device 13000 further includes one or more memory 13130, such as random access memory (RAM) for temporary storage of information, one or more read only memory (ROM) for permanent storage of information, and one or more mass storage device 13120, such as a hard drive, diskette, solid state drive, or optical media storage device. In certain embodiments, the processing device, cloud server, server or gateway device, may be implemented as a computing system 1300. In one embodiment, the modules of the computing system 13000 are connected to the computer using a standard based bus system. In different embodiments, the standard based bus system could be implemented in Peripheral Component Interconnect (PCI), Microchannel, Small Computer computing system Interface (SCSI), Industrial Standard Architecture (ISA) and Extended ISA (EISA) architectures, for example. In addition, the functionality provided for in the components and modules of computing device 13000 may be combined into fewer components and modules or further separated into additional components and modules.
The computing device 13000 may be controlled and coordinated by operating system software, for example, iOS, Windows XP, Windows Vista, Windows 7, Windows 8, Windows 10, Windows Server, Embedded Windows, Unix, Linux, Ubuntu Linux, SunOS, Solaris, Blackberry OS, Android, or other operating systems. In Macintosh systems, the operating system may be any available operating system, such as MAC OS X. In other embodiments, the computing device 13000 may be controlled by a proprietary operating system. Conventional operating systems control and schedule computer processes for execution, perform memory management, provide file system, networking, I/O services, and provide a user interface, such as a graphical user interface (GUI), among other things.
The exemplary computing device 13000 may include one or more I/O interfaces and devices 13110, for example, a touchpad or touchscreen, but could also include a keyboard, mouse, and printer. In one embodiment, the I/O interfaces and devices 13110 include one or more display devices (such as a touchscreen or monitor) that allow visual presentation of data to a user. More particularly, a display device may provide for the presentation of GUIs, application software data, and multimedia presentations, for example. The computing system 13000 may also include one or more multimedia devices 13140, such as cameras, speakers, video cards, graphics accelerators, and microphones, for example.
The I/O interfaces and devices 13110, in one embodiment of the computing system and application tools, may provide a communication interface to various external devices. In one embodiment, the computing device 13000 is electronically coupled to a network 13002, which comprises one or more of a local area network, a wide area network, and/or the Internet, for example, via a wired, wireless, or combination of wired and wireless, communication link 13115. The network 13002 can communicate with various sensors, computing devices, and/or other electronic devices via wired or wireless communication links.
In some embodiments, the filter criteria, signals and data are processed by rhythm inference module an application tool according to the methods and systems described herein, may be provided to the computing system 13000 over the network 13002 from one or more data sources 13010. The data sources may include one or more internal and/or external databases, data sources, and physical data stores. The data sources 13010, external computing systems 13004 and the rhythm interface module 13190 may include databases for storing data (for example, feature data, raw signal data, patient data) according to the systems and methods described above, databases for storing data that has been processed (for example, data to be transmitted to the sensor, data to be sent to the clinician) according to the systems and methods described above. In one embodiment of
The computing system, in one embodiment, includes a rhythm interface module 13190 that may be stored in the mass storage device 13120 as executable software codes that are executed by the CPU 13105. The rhythm interface module 13190 may have a Feature Module 14010, an Alternate Data Module 14020, an Inference Module 14030, a Feedback Module 14040, a Sensor Data Database 14050, and a Rules Database 14060. These modules may include by way of example, components, such as software components, object-oriented software components, subroutines, segments of program code, drivers, firmware, microcode, circuitry, data, databases, data structures, tables, arrays, and variables. These modules are also configured to perform the processes disclosed herein including, in some embodiments, the processes described with respect to
In some embodiments of the present disclosure, the system can perform lossless compression on the output of the first set of layers in a neural network before transmitting the data to a remote server to process the data through the second set of layers in a neural network. The lossless compression algorithms may allow the original data to be perfectly reconstructed from compressed data. In some embodiments, the system can perform compression where the remote server can reconstruct the compressed data with an accuracy of a certain threshold, thus reducing loss.
In one example, a lossless compression scheme can be used to map between output encoded features and a shorter length representation. For an 8 bit integer, a value of 0 as a binary representation “00000000” can be the outputted encoded feature of the first subset of layers of the neural network from the ECG encoder 2230, but the lossless compression scheme can change the “00000000” 8 bit number representation to something else. The lossless compression scheme can have a mapping between values that are outputted from the ECG encoder 2230 to a compressed value. For example, the “0000000” 8 bit number representation from the ECG encoder 2230 can be represented by “10,” which only takes 2 bits instead of 8. The lossless compression scheme can use shorter bit length codes for more common output encoded features, whereas longer bit length codes are used for more rare encoded features. Advantageously, less data is transmitted to the remote server. For example, if there are much more 0 values outputting from the ECG encoder 2230, the lossless compression scheme can map a 0 value to “10”. However, if a value of 433 is rarely outputted from the ECG encoder 2230, the lossless compression scheme can map a 433 value with a binary representation of “110110001” to “5523”.
In some embodiments, the lossless decompressor 2504 can retrieve mapped values that are predetermined. In some embodiments, the lossless decompressor 2504 can retrieve mapped values that are static and do not change. The lossless decompressor 2504 can receive the mapped values from the lossless compressor 2502. The remote server 2228 can map the compressed data (e.g., the mapped values) to actual values that correspond to the ECG encoder 2230. For example, if the lossless decompressor 2504 receives a “10” value and a “5523” value, the lossless decompressor 2504 can map these values to “0” and “443” and output these values accordingly. These values can then be processed through the second subset of layers in the neural network via the classifier 2238.
Advantageously, the dimensionality of the data being transmitted from the patch to the server for a system that (1) encodes the data via a neural network and (2) compresses the encoded data can be smaller than a system with (1) just a neural network encoder (without the lossless compression). Moreover, using lossless compression enables more data to be transmitted to the remote server 2228 while still maintaining the integrity of the data itself because the data can be reconstructed via the lossless decompressor. To illustrate in an example, if there are a plot of 0 values very close to each other, the system can send a representative indication of the plot of 0 values instead of having to transmit all 0 values separately. Advantageously, the data that is being transmitted from the patch to the server can use less network throughput, and can work under tighter network constraints without sacrificing accuracy and performance of the neural network. Moreover, such compression can be another form of encryption that can further enhances the privacy and security of the data as the data travels through various networks from the patch 2226 to the remote server 2228.
As noted herein, some embodiments of the present disclosure train the neural network to compress data, such as via the ECG encoder 2230, through a first set of layers in a neural network in order to reduce the dimensionality of the output. The first set of layers of the neural network is trained to output a certain dimensionality. The compressed data is transmitted to a remote device that applies the output of the first set of layers to the second set of layers of the neural network, which can include the steps described herein, such as decoding the data or determining physiological characteristics of the data.
In traditional neural networks, systems use large number representations, such as a floating point number (e.g., 32 bits of data). A floating point number can represent a very large or very small value, with great precision to many decimal places. These traditional systems use such large number representations for very accurate training of the neural network and processing of data. However, using such large number representations result in inefficiencies in storing, processing, and transmitting the data.
Some embodiments in the present disclosure mitigate such drawbacks by quantizing data.
Such quantization can be optimized to have better lossless compression performance while balancing the overall performance of the neural network. The system can quantize the output of the first set of layers of the neural network before transmitting the data to the external server. In some embodiments, quantizing the data can include rounding (e.g., rounding to the nearest integer), truncating, or reducing the number of bits for the data representation.
In some embodiments, the amount of quantization can be determined to optimize the balance between efficiencies and accuracy. A more aggressive quantization (e.g., truncating more bits from the data) can reduce the size of the data representation to a lower number of bits, but can negatively affect the accuracy of the neural network predictions. However, a less aggressive quantization (e.g., truncating less bits from the data) can increase accuracy, but at the cost of increased storage and transmission requirements of the monitor device on the person, increased storage requirements by having to store larger data representations at both the patch 2226 and the remote server 2228, and increased network transfer of data between the patch 2226 and the remote server 2228.
A more aggressive quantization can introduce error into the quantized data, which can lead to degradation in performance of algorithms that use quantization, as noted herein. While a neural network can work to a certain degree in light of the error introduced by quantization, there will be a point where the error will significantly degrade the algorithm's performance. Thus, the amount of quantization can be optimized based on degradation in hardware efficiencies and accuracy of the neural network in its classifications via the classifier 2238.
In some embodiments, the neural network is trained to allow for more aggressive quantization schemes. For example, the neural network can be trained to maximize lossless compression performance. The neural network can be trained by introducing quantization during training in order to reduce degradation associated with the quantization. In some embodiments, the neural network is initially trained without the quantization. Then, the trained neural network is trained again with quantization. Advantageously, the training of the neural network takes into account the quantization. This is particularly relevant here where the neural network is divided into a first set of layers that run on the patch 2226 and a second set of layers that run on a remote server 2228. Advantageously, the results of such training can include a neural network and/or quantization that can better represent low amplitude signals from the quantization. Rather the neural network can adjust the values of its output (e.g., increasing the amplitude of the low amplitude signals) to ensure that the low amplitude signals are taken into consideration, such as by the classifier 2236 of the remote server 2228, to identify features in the signal. For example, the neural network can exaggerate the low amplitude signals such that the signals reach a threshold. Thus, even as the low amplitude signals are processed by the quantization, the remote server 2228 can still register the low amplitude signals. Other systems without such training of the neural network could simply clip the low amplitude signals via the quantization, and the classifier 2238 may not be able to identify features in such signals.
In some embodiments, both lossless compression and quantization can be optimized and applied. In some embodiments, the optimal lossless compression in lieu of the neural network and the quantization can be determined by modeling performance of different lossless compression algorithms or characteristics thereof. For example, the output of features of the neural network can be set to have a distribution centered at 0 with a standard deviation of 1. Then, the system can model how well certain lossless compression algorithms perform under various quantization schemes. For example, if the output of the first subset of layers of a neural network is 128 bits per second, the quantizer can quantize the data to output 100 bits per second. The optimization can be governed at least by the available network and/or network constraints (such as a set number of bits per second or a bit size for the data). Then, lossless compression models (e.g., as described herein) can be applied to find optimal performance on identified features of the neural network at the remote server.
In some embodiments, the optimization can be governed at least by the architecture of the encoder. For example, a first encoder design can be outputting 8 bits and a second encoder design can be outputting 4 bits but outputting at double the sample rate as the first encoder design. In this example, the network constraints can be the same for the first and second encoder. The first encoder design has a less aggressive quantization with fewer outputted features. However in some circumstances, the second encoder design can perform better because of the higher rate of feature generation, in spite of the higher quantization.
In some embodiments, the implementation of quantization into training can apply a tensorflow implementation. During training, the tensorflow can introduce the quantization in the forward pass, but the gradients will be computed without the quantization. This is done so that quantization errors are propagated through the network, but gradients are still smooth and will allow the weight updates to respond appropriately to the errors.
In some embodiments of the present disclosure, the system can quantify QT intervals, which can include quantifying the time between the Q and T morphological features presented in an individual heartbeat. An elongated time between these features can be indicative of a heart condition.
In traditional systems, quantifying the QT interval is typically accomplished by first identifying the different morphological features and simply measuring the difference between specific points on the features. However, systems that do not have access to the full raw ECG data may not be able to apply the traditional methods of quantifying the QT interval.
Described herein are some embodiments that may quantify QT intervals without having access to the full raw ECG signal. In some embodiments, the remote server can receive the encoded features from the encoder, and can reconstruct the ECG signal from the encoded features. Then, the remote server can use signal processing and algorithm techniques for locating morphological features.
In some embodiments, the remote server can train a machine learning algorithm to directly predict the QT interval from a segment of encoded features that contain a QT interval.
In some embodiments, the remote server can train a machine learning algorithm that directly predicts the average QT interval from a window of encoded features that contain one or more QT intervals.
In some embodiments, the system can generate a template beat that is representative of several beats. The template beat can be generated by averaging the raw ECG of a fixed window of samples surrounding a detected beat location. The QT interval can be derived from the template beat using the algorithm techniques or machine learning algorithms described herein.
In some embodiments, the patch can generate the template beat. In other embodiments, the remote server can generate the template beat from the received data from the patch. In some embodiments, the template beat can be processed and identified via data processing through the layers of the neural network. For example, the patch can generate the template beat and input the template beat into the neural network described herein.
In general, the word “module,” as used herein, refers to logic embodied in hardware or firmware, or to a collection of software instructions, possibly having entry and exit points, written in a programming language, such as, for example, Python, Java, Lua, C and/or C++. A software module may be compiled and linked into an executable program, installed in a dynamic link library, or may be written in an interpreted programming language such as, for example, BASIC, Perl, or Python. It will be appreciated that software modules may be callable from other modules or from themselves, and/or may be invoked in response to detected events or interrupts. Software modules configured for execution on computing devices may be provided on a computer readable medium, such as a compact disc, digital video disc, flash drive, or any other tangible medium. Such software code may be stored, partially or fully, on a memory device of the executing computing device, such as the computing system 13000, for execution by the computing device. Software instructions may be embedded in firmware, such as an EPROM. It will be further appreciated that hardware modules may be comprised of connected logic units, such as gates and flip-flops, and/or may be comprised of programmable units, such as programmable gate arrays or processors. The block diagrams disclosed herein may be implemented as modules. The modules described herein may be implemented as software modules, but may be represented in hardware or firmware. Generally, the modules described herein refer to logical modules that may be combined with other modules or divided into sub-modules despite their physical organization or storage.
Each of the processes, methods, and algorithms described in the preceding sections may be embodied in, and fully or partially automated by, code modules executed by one or more computer systems or computer processors comprising computer hardware. The code modules may be stored on any type of non-transitory computer-readable medium or computer storage device, such as hard drives, solid state memory, optical disc, and/or the like. The systems and modules may also be transmitted as generated data signals (for example, as part of a carrier wave or other analog or digital propagated signal) on a variety of computer-readable transmission mediums, including wireless-based and wired/cable-based mediums, and may take a variety of forms (for example, as part of a single or multiplexed analog signal, or as multiple discrete digital packets or frames). The processes and algorithms may be implemented partially or wholly in application-specific circuitry. The results of the disclosed processes and process steps may be stored, persistently or otherwise, in any type of non-transitory computer storage such as, for example, volatile or non-volatile storage.
The various features and processes described above may be used independently of one another, or may be combined in various ways. All possible combinations and subcombinations are intended to fall within the scope of this disclosure. In addition, certain method or process blocks may be omitted in some implementations. The methods and processes described herein are also not limited to any particular sequence, and the blocks or states relating thereto can be performed in other sequences that are appropriate. For example, described blocks or states may be performed in an order other than that specifically disclosed, or multiple blocks or states may be combined in a single block or state. The example blocks or states may be performed in serial, in parallel, or in some other manner. Blocks or states may be added to or removed from the disclosed example embodiments. The example systems and components described herein may be configured differently than described. For example, elements may be added to, removed from, or rearranged compared to the disclosed example embodiments.
Conditional language, such as, among others, “can,” “could,” “might,” or “may,” unless specifically stated otherwise, or otherwise understood within the context as used, is generally intended to convey that certain embodiments include, while other embodiments do not include, certain features, elements and/or steps. Thus, such conditional language is not generally intended to imply that features, elements and/or steps are in any way required for one or more embodiments or that one or more embodiments necessarily include logic for deciding, with or without user input or prompting, whether these features, elements and/or steps are included or are to be performed in any particular embodiment. The term “including” means “included but not limited to.” The term “or” means “and/or.”
Any process descriptions, elements, or blocks in the flow or block diagrams described herein and/or depicted in the attached figures should be understood as potentially representing modules, segments, or portions of code which include one or more executable instructions for implementing specific logical functions or steps in the process. Alternate implementations are included within the scope of the embodiments described herein in which elements or functions may be deleted, executed out of order from that shown or discussed, including substantially concurrently or in reverse order, depending on the functionality involved, as would be understood by those skilled in the art.
All of the methods and processes described above may be at least partially embodied in, and partially or fully automated via, software code modules executed by one or more computers. For example, the methods described herein may be performed by the computing system and/or any other suitable computing device. The methods may be executed on the computing devices in response to execution of software instructions or other executable code read from a tangible computer readable medium. A tangible computer readable medium is a data storage device that can store data that is readable by a computer system. Examples of computer readable mediums include read-only memory, random-access memory, other volatile or non-volatile memory devices, CD-ROMs, magnetic tape, flash drives, and optical data storage devices.
It should be emphasized that many variations and modifications may be made to the above-described embodiments, the elements of which are to be understood as being among other acceptable examples. All such modifications and variations are intended to be included herein within the scope of this disclosure. The foregoing description details certain embodiments. It will be appreciated, however, that no matter how detailed the foregoing appears in text, the systems and methods can be practiced in many ways. For example, a feature of one embodiment may be used with a feature in a different embodiment. As is also stated above, it should be noted that the use of particular terminology when describing certain features or aspects of the systems and methods should not be taken to imply that the terminology is being re-defined herein to be restricted to including any specific characteristics of the features or aspects of the systems and methods with which that terminology is associated.
Various embodiments of a physiological monitoring device, methods, and systems are disclosed herein. These various embodiments may be used alone or in combination, and various changes to individual features of the embodiments may be altered, without departing from the scope of the invention. For example, the order of various method steps may in some instances be changed, and/or one or more optional features may be added to or eliminated from a described device. Therefore, the description of the embodiments provided above should not be interpreted as unduly limiting the scope of the invention as it is set forth in the claims.
Various modifications to the implementations described in this disclosure may be made, and the generic principles defined herein may be applied to other implementations without departing from the spirit or scope of this disclosure. Thus, the scope of the disclosure is not intended to be limited to the implementations shown herein, but are to be accorded the widest scope consistent with this disclosure, the principles and the novel features disclosed herein.
Certain features that are described in this specification in the context of separate embodiments also can be implemented in combination in a single embodiment. Conversely, various features that are described in the context of a single embodiment also can be implemented in multiple embodiments separately or in any suitable subcombination. Moreover, although features may be described above as acting in certain combinations and even initially claimed as such, one or more features from a claimed combination can in some cases be excised from the combination, and the claimed combination may be directed to a subcombination or variation of a subcombination.
Similarly, while operations are depicted in the drawings in a particular order, such operations need not be performed in the particular order shown or in sequential order, or that all illustrated operations be performed, to achieve desirable results. Further, the drawings may schematically depict one more example processes in the form of a flow diagram. However, other operations that are not depicted can be incorporated in the example processes that are schematically illustrated. For example, one or more additional operations can be performed before, after, simultaneously, or between any of the illustrated operations. Moreover, the separation of various system components in the embodiments described above should not be interpreted as requiring such separation in all embodiments. Additionally, other embodiments are within the scope of the following claims. In some cases, the actions recited in the claims can be performed in a different order and still achieve desirable results.
This application claims priority from U.S. patent application Ser. No. 17/397,075, filed Aug. 9, 2021, which claims priority from U.S. patent application Ser. No. 17/174,145, filed Feb. 11, 2021, which claims priority from provisional U.S. Pat. App. No. 62/975,626, filed on Feb. 12, 2020 and from provisional U.S. Pat. App. No. 63/090,951, filed on Oct. 13, 2020, which are hereby incorporated by reference in their entirety.
| Number | Name | Date | Kind |
|---|---|---|---|
| 1497079 | Gullborg | Jun 1924 | A |
| 2179922 | Dana | Nov 1939 | A |
| 2201645 | Epner | May 1940 | A |
| 2311060 | Lurrain | Feb 1943 | A |
| 2444552 | Sigurd | Jul 1948 | A |
| 2500840 | Lyons | Mar 1950 | A |
| 3215136 | Holter et al. | Nov 1965 | A |
| 3547107 | Chapman et al. | Dec 1970 | A |
| 3697706 | Huggard | Oct 1972 | A |
| 3870034 | James | Mar 1975 | A |
| 3882853 | Gofman | May 1975 | A |
| 3911906 | Reinhold | Oct 1975 | A |
| 4023312 | Stickney | May 1977 | A |
| 4027664 | Heavner, Jr. et al. | Jun 1977 | A |
| 4082087 | Howson | Apr 1978 | A |
| 4121573 | Crovella et al. | Oct 1978 | A |
| 4123785 | Cherry et al. | Oct 1978 | A |
| 4126126 | Bare | Nov 1978 | A |
| 4202139 | Hong et al. | May 1980 | A |
| 4274419 | Tam et al. | Jun 1981 | A |
| 4274420 | Hymes | Jun 1981 | A |
| 4286610 | Jones | Sep 1981 | A |
| 4333475 | Moreno et al. | Jun 1982 | A |
| 4361990 | Link | Dec 1982 | A |
| 4381792 | Busch | May 1983 | A |
| 4438767 | Nelson | Mar 1984 | A |
| 4459987 | Pangburn | Jul 1984 | A |
| 4535783 | Marangoni | Aug 1985 | A |
| 4537207 | Gilhaus | Aug 1985 | A |
| 4572187 | Schetrumpf | Feb 1986 | A |
| 4621465 | Pangburn | Nov 1986 | A |
| 4622979 | Katchis et al. | Nov 1986 | A |
| 4658826 | Weaver | Apr 1987 | A |
| 4712552 | Pangburn | Dec 1987 | A |
| 4736752 | Munck et al. | Apr 1988 | A |
| 4855294 | Patel | Aug 1989 | A |
| 4925453 | Kannankeril | May 1990 | A |
| 4938228 | Righter et al. | Jul 1990 | A |
| 4981141 | Segalowitz | Jan 1991 | A |
| 5003987 | Grinwald | Apr 1991 | A |
| 5027824 | Dougherty et al. | Jul 1991 | A |
| 5082851 | Appelbaum et al. | Jan 1992 | A |
| 5086778 | Mueller et al. | Feb 1992 | A |
| 5191891 | Righter | Mar 1993 | A |
| 5205295 | Del Mar et al. | Apr 1993 | A |
| 5226425 | Righter | Jul 1993 | A |
| 5228450 | Sellers | Jul 1993 | A |
| 5230119 | Woods et al. | Jul 1993 | A |
| 5289824 | Mills et al. | Mar 1994 | A |
| 5305746 | Fendrock | Apr 1994 | A |
| 5309909 | Gadsby | May 1994 | A |
| 5328935 | Van Phan | Jul 1994 | A |
| 5365935 | Righter et al. | Nov 1994 | A |
| 5458141 | Neil | Oct 1995 | A |
| 5483967 | Ohtake | Jan 1996 | A |
| 5489624 | Kantner et al. | Feb 1996 | A |
| 5511553 | Segalowitz | Apr 1996 | A |
| 5515858 | Myllymaki | May 1996 | A |
| 5536768 | Kantner et al. | Jul 1996 | A |
| 5581369 | Righter et al. | Dec 1996 | A |
| 5626140 | Feldman et al. | May 1997 | A |
| 5634468 | Platt et al. | Jun 1997 | A |
| 5645063 | Straka | Jul 1997 | A |
| 5645068 | Mezack et al. | Jul 1997 | A |
| 5730143 | Schwarzberg | Mar 1998 | A |
| 5749365 | Magill | May 1998 | A |
| 5749367 | Gamlyn et al. | May 1998 | A |
| 5771524 | Woods et al. | Jun 1998 | A |
| 5772604 | Langberg et al. | Jun 1998 | A |
| 5776072 | Hsu et al. | Jul 1998 | A |
| 5881743 | Nadel | Mar 1999 | A |
| D408541 | Dunshee et al. | Apr 1999 | S |
| 5916239 | Geddes et al. | Jun 1999 | A |
| 5931791 | Saltzstein et al. | Aug 1999 | A |
| 5941829 | Saltzstein et al. | Aug 1999 | A |
| 5957854 | Besson et al. | Sep 1999 | A |
| 5959529 | Kail | Sep 1999 | A |
| 6013007 | Root et al. | Jan 2000 | A |
| 6032060 | Carim | Feb 2000 | A |
| 6038464 | Axelgaard et al. | Mar 2000 | A |
| 6038469 | Karlsson et al. | Mar 2000 | A |
| 6044515 | Zygmont | Apr 2000 | A |
| 6093146 | Filangeri | Jul 2000 | A |
| D429336 | Francis et al. | Aug 2000 | S |
| 6102856 | Groff et al. | Aug 2000 | A |
| 6117077 | Del Mar et al. | Sep 2000 | A |
| 6121508 | Bischof | Sep 2000 | A |
| 6132371 | Dempsey et al. | Oct 2000 | A |
| 6134480 | Minogue | Oct 2000 | A |
| 6136008 | Becker et al. | Oct 2000 | A |
| 6161036 | Matsumura et al. | Dec 2000 | A |
| 6169915 | Krumbiegel et al. | Jan 2001 | B1 |
| 6178357 | Gliner et al. | Jan 2001 | B1 |
| 6200265 | Walsh et al. | Mar 2001 | B1 |
| 6225901 | Kail | May 2001 | B1 |
| 6232366 | Wang et al. | May 2001 | B1 |
| 6238338 | DeLuca et al. | May 2001 | B1 |
| 6248115 | Halk | Jun 2001 | B1 |
| 6287252 | Lugo | Sep 2001 | B1 |
| 6290707 | Street | Sep 2001 | B1 |
| 6315719 | Rode et al. | Nov 2001 | B1 |
| 6379237 | Gordon | Apr 2002 | B1 |
| 6385473 | Haines et al. | May 2002 | B1 |
| 6389308 | Shusterman | May 2002 | B1 |
| 6416471 | Kumar et al. | Jul 2002 | B1 |
| 6434410 | Cordero et al. | Aug 2002 | B1 |
| 6441747 | Khair et al. | Aug 2002 | B1 |
| 6454708 | Ferguson et al. | Sep 2002 | B1 |
| 6456871 | Hsu et al. | Sep 2002 | B1 |
| 6456872 | Faisandier | Sep 2002 | B1 |
| 6464815 | Beaudry | Oct 2002 | B1 |
| 6493898 | Woods et al. | Dec 2002 | B1 |
| 6496705 | Ng et al. | Dec 2002 | B1 |
| 6510339 | Kovtun et al. | Jan 2003 | B2 |
| 6546285 | Owen et al. | Apr 2003 | B1 |
| 6564090 | Taha et al. | May 2003 | B2 |
| 6569095 | Eggers | May 2003 | B2 |
| 6577893 | Besson et al. | Jun 2003 | B1 |
| 6580942 | Willshire | Jun 2003 | B1 |
| 6585707 | Cabiri et al. | Jul 2003 | B2 |
| 6589170 | Flach et al. | Jul 2003 | B1 |
| 6589187 | Dimberger et al. | Jul 2003 | B1 |
| 6605046 | Del Mar et al. | Aug 2003 | B1 |
| 6615083 | Kupper | Sep 2003 | B2 |
| 6622035 | Merilainen | Sep 2003 | B1 |
| 6626865 | Prisell | Sep 2003 | B1 |
| 6656125 | Misczynski et al. | Dec 2003 | B2 |
| 6664893 | Eveland et al. | Dec 2003 | B1 |
| 6665385 | Rogers et al. | Dec 2003 | B2 |
| 6690959 | Thompson | Feb 2004 | B2 |
| 6694177 | Eggers et al. | Feb 2004 | B2 |
| 6701184 | Henkin | Mar 2004 | B2 |
| 6711427 | Ketelhohn | Mar 2004 | B1 |
| 6730028 | Eppstein | May 2004 | B2 |
| D492607 | Curkovic et al. | Jul 2004 | S |
| 6773396 | Flach et al. | Aug 2004 | B2 |
| 6775566 | Nissila | Aug 2004 | B2 |
| 6801137 | Eggers | Oct 2004 | B2 |
| 6801802 | Sitzman et al. | Oct 2004 | B2 |
| 6871089 | Korzinov et al. | Mar 2005 | B2 |
| 6871211 | Labounty et al. | Mar 2005 | B2 |
| 6875174 | Braun et al. | Apr 2005 | B2 |
| 6881191 | Oakley et al. | Apr 2005 | B2 |
| 6893396 | Schulze et al. | May 2005 | B2 |
| 6897788 | Khair et al. | May 2005 | B2 |
| 6904312 | Bardy | Jun 2005 | B2 |
| 6925324 | Shusterman | Aug 2005 | B2 |
| 6940403 | Kail | Sep 2005 | B2 |
| 6954163 | Toumazou et al. | Oct 2005 | B2 |
| 6957107 | Rogers et al. | Oct 2005 | B2 |
| 6987965 | Ng et al. | Jan 2006 | B2 |
| 7002468 | Eveland et al. | Feb 2006 | B2 |
| 7020508 | Stivoric et al. | Mar 2006 | B2 |
| 7024248 | Penner et al. | Apr 2006 | B2 |
| 7031770 | Collins et al. | Apr 2006 | B2 |
| 7072708 | Andresen et al. | Jul 2006 | B1 |
| 7072709 | Xue | Jul 2006 | B2 |
| 7076283 | Cho et al. | Jul 2006 | B2 |
| 7076287 | Rowlandson | Jul 2006 | B2 |
| 7076288 | Skinner | Jul 2006 | B2 |
| 7076289 | Sarkar et al. | Jul 2006 | B2 |
| 7079977 | Osorio et al. | Jul 2006 | B2 |
| 7082327 | Houben | Jul 2006 | B2 |
| 7089048 | Matsumura et al. | Aug 2006 | B2 |
| 7099715 | Korzinov et al. | Aug 2006 | B2 |
| 7117031 | Lohman et al. | Oct 2006 | B2 |
| 7120485 | Glass et al. | Oct 2006 | B2 |
| 7130396 | Rogers et al. | Oct 2006 | B2 |
| 7161484 | Tsoukalis | Jan 2007 | B2 |
| 7171166 | Ng et al. | Jan 2007 | B2 |
| 7179152 | Rhoades | Feb 2007 | B1 |
| 7186264 | Liddicoat et al. | Mar 2007 | B2 |
| 7193264 | Lande | Mar 2007 | B2 |
| 7194300 | Korzinov | Mar 2007 | B2 |
| 7206630 | Tarler | Apr 2007 | B1 |
| 7212850 | Prystowsky et al. | May 2007 | B2 |
| 7222054 | Geva | May 2007 | B2 |
| 7242318 | Harris | Jul 2007 | B2 |
| 7266361 | Burdett | Sep 2007 | B2 |
| 7316671 | Lastovich et al. | Jan 2008 | B2 |
| 7349947 | Slage et al. | Mar 2008 | B1 |
| D567949 | Lash et al. | Apr 2008 | S |
| 7354423 | Zelickson et al. | Apr 2008 | B2 |
| 7387607 | Holt et al. | Jun 2008 | B2 |
| 7444177 | Nazeri | Oct 2008 | B2 |
| D584414 | Lash et al. | Jan 2009 | S |
| 7477933 | Ueyama | Jan 2009 | B2 |
| 7478108 | Townsend et al. | Jan 2009 | B2 |
| 7481772 | Banet | Jan 2009 | B2 |
| 7482314 | Grimes et al. | Jan 2009 | B2 |
| 7502643 | Farringdon et al. | Mar 2009 | B2 |
| 7539533 | Tran | May 2009 | B2 |
| 7542878 | Nanikashvili | Jun 2009 | B2 |
| 7587237 | Korzinov et al. | Sep 2009 | B2 |
| 7630756 | Linker | Dec 2009 | B2 |
| 7632174 | Gringer et al. | Dec 2009 | B2 |
| 7672714 | Kuo et al. | Mar 2010 | B2 |
| 7715905 | Kurzweil et al. | May 2010 | B2 |
| D618357 | Navies | Jun 2010 | S |
| 7729753 | Kremliovsky et al. | Jun 2010 | B2 |
| 7733224 | Tran | Jun 2010 | B2 |
| D621048 | Severe et al. | Aug 2010 | S |
| 7815494 | Gringer et al. | Oct 2010 | B2 |
| 7841039 | Squire | Nov 2010 | B1 |
| 7889070 | Reeves et al. | Feb 2011 | B2 |
| D634431 | Severe et al. | Mar 2011 | S |
| 7904133 | Gehman et al. | Mar 2011 | B2 |
| 7907956 | Uhlik | Mar 2011 | B2 |
| 7907996 | Prystowsky et al. | Mar 2011 | B2 |
| 7941207 | Korzinov | May 2011 | B2 |
| D639437 | Bishay et al. | Jun 2011 | S |
| 7970450 | Kroecker et al. | Jun 2011 | B2 |
| 7979111 | Acquista | Jul 2011 | B2 |
| 7996075 | Korzinov et al. | Aug 2011 | B2 |
| 7996187 | Nanikashvili et al. | Aug 2011 | B2 |
| 8002701 | John et al. | Aug 2011 | B2 |
| D645968 | Kasabach et al. | Sep 2011 | S |
| 8077042 | Peeters | Dec 2011 | B2 |
| 8103333 | Tran | Jan 2012 | B2 |
| 8108036 | Tran | Jan 2012 | B2 |
| 8170639 | Hauge | Jan 2012 | B2 |
| 8116841 | Bly et al. | Feb 2012 | B2 |
| 8150502 | Kumar et al. | Apr 2012 | B2 |
| 8156945 | Hart | Apr 2012 | B2 |
| 8160682 | Kumar et al. | Apr 2012 | B2 |
| D659836 | Bensch et al. | May 2012 | S |
| 8200319 | Pu et al. | Jun 2012 | B2 |
| D663432 | Nichols | Jul 2012 | S |
| 8214007 | Baker et al. | Jul 2012 | B2 |
| 8244335 | Kumar et al. | Aug 2012 | B2 |
| 8249686 | Libbus et al. | Aug 2012 | B2 |
| 8261754 | Pitstick | Sep 2012 | B2 |
| 8265907 | Nanikashvili et al. | Sep 2012 | B2 |
| RE43767 | Eggers et al. | Oct 2012 | E |
| 8280749 | Hsieh et al. | Oct 2012 | B2 |
| 8285356 | Bly et al. | Oct 2012 | B2 |
| 8290129 | Rogers et al. | Oct 2012 | B2 |
| 8290574 | Field et al. | Oct 2012 | B2 |
| 8301219 | Chen et al. | Oct 2012 | B2 |
| 8301236 | Baumann et al. | Oct 2012 | B2 |
| 8311604 | Rowlandson et al. | Nov 2012 | B2 |
| 8315687 | Cross et al. | Nov 2012 | B2 |
| 8315695 | Sebelius et al. | Nov 2012 | B2 |
| 8323188 | Tran | Dec 2012 | B2 |
| 8326394 | Rowlandson et al. | Dec 2012 | B2 |
| 8326407 | Linker | Dec 2012 | B2 |
| 8328718 | Tran | Dec 2012 | B2 |
| D674009 | Nichols | Jan 2013 | S |
| 8343116 | Ignon | Jan 2013 | B2 |
| 8369936 | Farringdon et al. | Feb 2013 | B2 |
| 8374688 | Libbus et al. | Feb 2013 | B2 |
| 8386009 | Lindberg et al. | Feb 2013 | B2 |
| 8388543 | Chon et al. | Mar 2013 | B2 |
| 8406843 | Tiegs et al. | Mar 2013 | B2 |
| 8412317 | Mazar | Apr 2013 | B2 |
| 8417326 | Chon et al. | Apr 2013 | B2 |
| 8425414 | Eveland | Apr 2013 | B2 |
| 8449471 | Tran | May 2013 | B2 |
| 8452356 | Vestel et al. | May 2013 | B2 |
| 8460189 | Libbus et al. | Jun 2013 | B2 |
| 8473039 | Michelson et al. | Jun 2013 | B2 |
| 8473047 | Chakravarthy et al. | Jun 2013 | B2 |
| 8478418 | Fahey | Jul 2013 | B2 |
| 8483809 | Kim et al. | Jul 2013 | B2 |
| 8500636 | Tran | Aug 2013 | B2 |
| 8515529 | Pu et al. | Aug 2013 | B2 |
| 8525673 | Tran | Sep 2013 | B2 |
| 8535223 | Corroy et al. | Sep 2013 | B2 |
| 8538503 | Kumar et al. | Sep 2013 | B2 |
| 8540731 | Kay | Sep 2013 | B2 |
| 8560046 | Kumar et al. | Oct 2013 | B2 |
| 8562527 | Braun et al. | Oct 2013 | B2 |
| 8571645 | Wu et al. | Oct 2013 | B2 |
| 8588908 | Moorman et al. | Nov 2013 | B2 |
| 8591430 | Amurthur et al. | Nov 2013 | B2 |
| 8591599 | Kaliki | Nov 2013 | B1 |
| 8594763 | Bibian | Nov 2013 | B1 |
| 8626262 | McGusty et al. | Jan 2014 | B2 |
| 8639319 | Hugh et al. | Jan 2014 | B2 |
| 8668643 | Kinast | Mar 2014 | B2 |
| 8684900 | Tran | Apr 2014 | B2 |
| 8684925 | Amurthur et al. | Apr 2014 | B2 |
| 8688189 | Shennib | Apr 2014 | B2 |
| 8688190 | Libbus et al. | Apr 2014 | B2 |
| 8688202 | Brockway et al. | Apr 2014 | B2 |
| 8718742 | Beck et al. | May 2014 | B2 |
| 8718752 | Libbus et al. | May 2014 | B2 |
| 8718753 | Chon et al. | May 2014 | B2 |
| 8731632 | Sereboff et al. | May 2014 | B1 |
| 8738118 | Moon et al. | May 2014 | B2 |
| 8744561 | Fahey | Jun 2014 | B2 |
| 8755876 | Chon et al. | Jun 2014 | B2 |
| 8782308 | Vlach | Jul 2014 | B2 |
| 8789727 | Mortazavi | Jul 2014 | B2 |
| 8790257 | Libbus et al. | Jul 2014 | B2 |
| 8795174 | Manicka et al. | Aug 2014 | B2 |
| 8818481 | Bly et al. | Aug 2014 | B2 |
| 8823490 | Libbus et al. | Sep 2014 | B2 |
| 8838218 | Khair | Sep 2014 | B2 |
| 8858450 | Chon et al. | Oct 2014 | B2 |
| 8874185 | Sonnenborg | Oct 2014 | B2 |
| D719267 | Vaccarella | Dec 2014 | S |
| 8903477 | Berkner | Dec 2014 | B2 |
| 8903484 | Mazar | Dec 2014 | B2 |
| 8909328 | Chon | Dec 2014 | B2 |
| 8909330 | McCombie et al. | Dec 2014 | B2 |
| 8909332 | Vitali et al. | Dec 2014 | B2 |
| 8909333 | Rossi | Dec 2014 | B2 |
| 8909832 | Vlach et al. | Dec 2014 | B2 |
| 8926509 | Magar et al. | Jan 2015 | B2 |
| 8945019 | Prystowsky et al. | Feb 2015 | B2 |
| 8948854 | Friedman et al. | Feb 2015 | B2 |
| 8954129 | Schlegel et al. | Feb 2015 | B1 |
| 8956293 | McCombie et al. | Feb 2015 | B2 |
| 8968195 | Tran | Mar 2015 | B2 |
| 8972000 | Manera | Mar 2015 | B2 |
| 8979755 | Szydlo-Moore et al. | Mar 2015 | B2 |
| 9014777 | Woo | Apr 2015 | B2 |
| 9015008 | Geva et al. | Apr 2015 | B2 |
| 9017255 | Raptis et al. | Apr 2015 | B2 |
| 9017256 | Gottesman | Apr 2015 | B2 |
| 9021161 | Vlach et al. | Apr 2015 | B2 |
| 9021165 | Vlach | Apr 2015 | B2 |
| 9026190 | Shenasa et al. | May 2015 | B2 |
| 9037223 | Oral et al. | May 2015 | B2 |
| 9044148 | Michelson et al. | Jun 2015 | B2 |
| 9084548 | Bouguerra | Jul 2015 | B2 |
| 9095274 | Fein et al. | Aug 2015 | B2 |
| 9101264 | Acquista | Aug 2015 | B2 |
| 9138144 | Geva | Sep 2015 | B2 |
| 9149228 | Kinast | Oct 2015 | B2 |
| 9173670 | Sepulveda et al. | Nov 2015 | B2 |
| 9179851 | Baumann et al. | Nov 2015 | B2 |
| D744659 | Bishay et al. | Dec 2015 | S |
| 9211076 | Kim | Dec 2015 | B2 |
| 9226679 | Baida | Jan 2016 | B2 |
| 9241649 | Kumar et al. | Jan 2016 | B2 |
| 9241650 | Amirim | Jan 2016 | B2 |
| 9277864 | Yang et al. | Mar 2016 | B2 |
| 9282894 | Banet et al. | Mar 2016 | B2 |
| 9307921 | Friedman et al. | Apr 2016 | B2 |
| 9345414 | Bardy et al. | May 2016 | B1 |
| 9355215 | Vlach | May 2016 | B2 |
| D759653 | Toth et al. | Jun 2016 | S |
| 9357939 | Nosrati | Jun 2016 | B1 |
| 9364150 | Sebelius et al. | Jun 2016 | B2 |
| 9364155 | Bardy et al. | Jun 2016 | B2 |
| 9398853 | Nanikashvili | Jul 2016 | B2 |
| 9408545 | Felix et al. | Aug 2016 | B2 |
| 9408551 | Bardy et al. | Aug 2016 | B2 |
| 9408576 | Chon et al. | Aug 2016 | B2 |
| 9414753 | Chon et al. | Aug 2016 | B2 |
| 9414786 | Brockway et al. | Aug 2016 | B1 |
| D766447 | Bishay et al. | Sep 2016 | S |
| 9433367 | Felix et al. | Sep 2016 | B2 |
| 9433380 | Bishay et al. | Sep 2016 | B1 |
| 9439566 | Arne et al. | Sep 2016 | B2 |
| 9439599 | Thompson et al. | Sep 2016 | B2 |
| 9445719 | Libbus et al. | Sep 2016 | B2 |
| 9451890 | Gitlin et al. | Sep 2016 | B2 |
| 9451975 | Sepulveda et al. | Sep 2016 | B2 |
| 9474445 | Eveland | Oct 2016 | B2 |
| 9474461 | Fisher et al. | Oct 2016 | B2 |
| 9478998 | Lapetina et al. | Oct 2016 | B1 |
| D773056 | Vlach | Nov 2016 | S |
| 9492084 | Behar et al. | Nov 2016 | B2 |
| 9504423 | Bardy et al. | Nov 2016 | B1 |
| D775361 | Vosch et al. | Dec 2016 | S |
| 9510764 | Li et al. | Dec 2016 | B2 |
| 9510768 | Rossi | Dec 2016 | B2 |
| 9526433 | Lapetina et al. | Dec 2016 | B2 |
| 9545204 | Bishay et al. | Jan 2017 | B2 |
| 9545228 | Bardy et al. | Jan 2017 | B2 |
| 9554715 | Bardy et al. | Jan 2017 | B2 |
| 9579020 | Libbus et al. | Feb 2017 | B2 |
| D780914 | Kyvik et al. | Mar 2017 | S |
| 9585584 | Marek et al. | Mar 2017 | B2 |
| 9597004 | Hughes et al. | Mar 2017 | B2 |
| 9615763 | Felix et al. | Apr 2017 | B2 |
| 9615793 | Solosko et al. | Apr 2017 | B2 |
| 9619660 | Felix et al. | Apr 2017 | B1 |
| 9642537 | Felix et al. | May 2017 | B2 |
| 9655518 | Lin | May 2017 | B2 |
| 9655537 | Bardy et al. | May 2017 | B2 |
| 9655538 | Felix | May 2017 | B2 |
| 9662030 | Thng et al. | May 2017 | B2 |
| 9675264 | Acquista et al. | Jun 2017 | B2 |
| 9700227 | Bishay et al. | Jun 2017 | B2 |
| 9706938 | Chakravarthy et al. | Jul 2017 | B2 |
| 9706956 | Brockway et al. | Jul 2017 | B2 |
| 9713428 | Chon et al. | Jul 2017 | B2 |
| D793566 | Bishay et al. | Aug 2017 | S |
| 9717432 | Bardy et al. | Aug 2017 | B2 |
| 9717433 | Felix et al. | Aug 2017 | B2 |
| 9730593 | Bardy et al. | Aug 2017 | B2 |
| 9730604 | Li et al. | Aug 2017 | B2 |
| 9730641 | Felix et al. | Aug 2017 | B2 |
| 9736625 | Landgraf et al. | Aug 2017 | B1 |
| 9737211 | Bardy et al. | Aug 2017 | B2 |
| 9737224 | Bardy et al. | Aug 2017 | B2 |
| D797301 | Chen | Sep 2017 | S |
| D797943 | Long | Sep 2017 | S |
| D798170 | Toth et al. | Sep 2017 | S |
| D798294 | Toth et al. | Sep 2017 | S |
| 9775534 | Korzinov et al. | Oct 2017 | B2 |
| 9775536 | Felix et al. | Oct 2017 | B2 |
| 9782095 | Ylostalo et al. | Oct 2017 | B2 |
| 9782132 | Golda et al. | Oct 2017 | B2 |
| 9788722 | Bardy et al. | Oct 2017 | B2 |
| 9820665 | Felix et al. | Nov 2017 | B2 |
| 9839363 | Albert | Dec 2017 | B2 |
| D810308 | Lind et al. | Feb 2018 | S |
| D811610 | Abel et al. | Feb 2018 | S |
| D811611 | Lind et al. | Feb 2018 | S |
| D811615 | Lind et al. | Feb 2018 | S |
| 9888866 | Chon et al. | Feb 2018 | B2 |
| 9901274 | Bishay et al. | Feb 2018 | B2 |
| 9907478 | Friedman et al. | Mar 2018 | B2 |
| 9936875 | Bardy et al. | Apr 2018 | B2 |
| 9955885 | Felix et al. | May 2018 | B2 |
| 9955887 | Hughes et al. | May 2018 | B2 |
| 9955888 | Felix et al. | May 2018 | B2 |
| 9955911 | Bardy et al. | May 2018 | B2 |
| 9968274 | Korzinov et al. | May 2018 | B2 |
| 9986921 | Chon et al. | Jun 2018 | B2 |
| 10004415 | Bishay et al. | Jun 2018 | B2 |
| D823466 | Marogil | Jul 2018 | S |
| D824526 | Ramjit et al. | Jul 2018 | S |
| 10045709 | Bardy et al. | Aug 2018 | B2 |
| 10052022 | Bardy et al. | Aug 2018 | B2 |
| 10095841 | Dettinger et al. | Oct 2018 | B2 |
| 10098559 | Hughes et al. | Oct 2018 | B2 |
| 10111601 | Bishay et al. | Oct 2018 | B2 |
| 10123703 | Bardy et al. | Nov 2018 | B2 |
| 10154793 | Felix et al. | Dec 2018 | B2 |
| 10165946 | Bardy et al. | Jan 2019 | B2 |
| 10172534 | Felix et al. | Jan 2019 | B2 |
| 10251575 | Bardy et al. | Apr 2019 | B2 |
| 10251576 | Bardy et al. | Apr 2019 | B2 |
| 10264992 | Felix et al. | Apr 2019 | B2 |
| 10265015 | Bardy et al. | Apr 2019 | B2 |
| 10271754 | Bahney et al. | Apr 2019 | B2 |
| 10271755 | Felix et al. | Apr 2019 | B2 |
| 10271756 | Felix et al. | Apr 2019 | B2 |
| 10278603 | Felix et al. | May 2019 | B2 |
| 10278606 | Bishay et al. | May 2019 | B2 |
| 10278607 | Prystowsky et al. | May 2019 | B2 |
| 10299691 | Hughes et al. | May 2019 | B2 |
| 10321823 | Chakravarthy et al. | Jun 2019 | B2 |
| 10327657 | Spencer et al. | Jun 2019 | B2 |
| D852965 | Bahney et al. | Jul 2019 | S |
| D854167 | Bahney et al. | Jul 2019 | S |
| 10362467 | Landgraf et al. | Jul 2019 | B2 |
| 10368808 | Lee et al. | Aug 2019 | B2 |
| 10376172 | Kuppuraj et al. | Aug 2019 | B2 |
| 10390700 | Bardy et al. | Aug 2019 | B2 |
| 10398344 | Felix et al. | Sep 2019 | B2 |
| 10405799 | Kumar et al. | Sep 2019 | B2 |
| 10413205 | Bardy et al. | Sep 2019 | B2 |
| 10426634 | Al-Jazaeri et al. | Oct 2019 | B1 |
| 10433743 | Felix et al. | Oct 2019 | B1 |
| 10433748 | Bishay et al. | Oct 2019 | B2 |
| 10433751 | Bardy et al. | Oct 2019 | B2 |
| 10463269 | Boleyn et al. | Nov 2019 | B2 |
| 10478083 | Felix et al. | Nov 2019 | B2 |
| 10499812 | Bardy et al. | Dec 2019 | B2 |
| 10517500 | Kumar et al. | Dec 2019 | B2 |
| 10555683 | Bahney et al. | Feb 2020 | B2 |
| 10561326 | Felix et al. | Feb 2020 | B2 |
| 10561328 | Bishay et al. | Feb 2020 | B2 |
| 10588527 | McNamara et al. | Mar 2020 | B2 |
| 10602977 | Bardy et al. | Mar 2020 | B2 |
| 10624551 | Bardy et al. | Apr 2020 | B2 |
| 10660520 | Lin | May 2020 | B2 |
| 10667712 | Park et al. | Jun 2020 | B2 |
| 10729361 | Hoppe et al. | Aug 2020 | B2 |
| 10758139 | Rapin et al. | Sep 2020 | B2 |
| 10772521 | Korzinov et al. | Sep 2020 | B2 |
| 10779744 | Rapin et al. | Sep 2020 | B2 |
| 10813565 | Park et al. | Oct 2020 | B2 |
| 10827938 | Fontanarava et al. | Nov 2020 | B2 |
| 11017887 | Finkelmeier et al. | May 2021 | B2 |
| 11051738 | Bahney et al. | Jul 2021 | B2 |
| 11083371 | Szabados et al. | Aug 2021 | B1 |
| 11141091 | Uday et al. | Oct 2021 | B2 |
| 20010056262 | Cabiri et al. | Dec 2001 | A1 |
| 20020007126 | Nissila | Jan 2002 | A1 |
| 20020026112 | Nissila et al. | Feb 2002 | A1 |
| 20020067256 | Kail | Jun 2002 | A1 |
| 20020082491 | Nissila | Jun 2002 | A1 |
| 20020087167 | Winitsky | Jul 2002 | A1 |
| 20020180605 | Ozguz et al. | Dec 2002 | A1 |
| 20030069510 | Semler | Apr 2003 | A1 |
| 20030083559 | Thompson | May 2003 | A1 |
| 20030125786 | Gliner | Jul 2003 | A1 |
| 20030149349 | Jensen | Aug 2003 | A1 |
| 20030176795 | Harris et al. | Sep 2003 | A1 |
| 20030195408 | Hastings | Oct 2003 | A1 |
| 20030199811 | Sage, Jr. et al. | Oct 2003 | A1 |
| 20030212319 | Magill | Nov 2003 | A1 |
| 20040032957 | Mansy et al. | Feb 2004 | A1 |
| 20040068195 | Massicotte et al. | Apr 2004 | A1 |
| 20040077954 | Oakley et al. | Apr 2004 | A1 |
| 20040082843 | Menon | Apr 2004 | A1 |
| 20040187297 | Su | Sep 2004 | A1 |
| 20040215091 | Lohman et al. | Oct 2004 | A1 |
| 20040236202 | Burton | Nov 2004 | A1 |
| 20040254587 | Park | Dec 2004 | A1 |
| 20040260189 | Eggers et al. | Dec 2004 | A1 |
| 20050096513 | Ozguz et al. | May 2005 | A1 |
| 20050101875 | Semler et al. | May 2005 | A1 |
| 20050118246 | Wong et al. | Jun 2005 | A1 |
| 20050119580 | Eveland | Jun 2005 | A1 |
| 20050165323 | Montgomery et al. | Jul 2005 | A1 |
| 20050204636 | Azar et al. | Sep 2005 | A1 |
| 20050277841 | Shennib | Dec 2005 | A1 |
| 20050280531 | Fadem et al. | Dec 2005 | A1 |
| 20060030781 | Shennib | Feb 2006 | A1 |
| 20060030782 | Shennib | Feb 2006 | A1 |
| 20060047215 | Newman et al. | Mar 2006 | A1 |
| 20060084883 | Linker | Apr 2006 | A1 |
| 20060142648 | Banet et al. | Jun 2006 | A1 |
| 20060142654 | Rytky | Jun 2006 | A1 |
| 20060149156 | Cochran et al. | Jul 2006 | A1 |
| 20060155173 | Anttila et al. | Jul 2006 | A1 |
| 20060155183 | Kroecker et al. | Jul 2006 | A1 |
| 20060155199 | Logier et al. | Jul 2006 | A1 |
| 20060155200 | Ng et al. | Jul 2006 | A1 |
| 20060161064 | Watrous et al. | Jul 2006 | A1 |
| 20060161065 | Elion | Jul 2006 | A1 |
| 20060161066 | Elion | Jul 2006 | A1 |
| 20060161067 | Elion | Jul 2006 | A1 |
| 20060161068 | Hastings et al. | Jul 2006 | A1 |
| 20060167353 | Nazeri | Jul 2006 | A1 |
| 20060224072 | Shennib | Oct 2006 | A1 |
| 20060264767 | Shennib | Nov 2006 | A1 |
| 20070003695 | Tregub et al. | Jan 2007 | A1 |
| 20070010729 | Virtanen | Jan 2007 | A1 |
| 20070027388 | Chou | Feb 2007 | A1 |
| 20070088419 | Florina et al. | Apr 2007 | A1 |
| 20070156054 | Korzinov et al. | Jul 2007 | A1 |
| 20070208266 | Hadley | Sep 2007 | A1 |
| 20070225611 | Kumar et al. | Sep 2007 | A1 |
| 20070249946 | Kumar et al. | Oct 2007 | A1 |
| 20070255153 | Kumar et al. | Nov 2007 | A1 |
| 20070270678 | Fadem et al. | Nov 2007 | A1 |
| 20070285868 | Lindberg et al. | Dec 2007 | A1 |
| 20070293776 | Korzinov et al. | Dec 2007 | A1 |
| 20080039730 | Pu et al. | Feb 2008 | A1 |
| 20080091089 | Guillory et al. | Apr 2008 | A1 |
| 20080108890 | Teng et al. | May 2008 | A1 |
| 20080114232 | Gazit | May 2008 | A1 |
| 20080139953 | Baker et al. | Jun 2008 | A1 |
| 20080214901 | Gehman et al. | Sep 2008 | A1 |
| 20080275327 | Faarbaek et al. | Nov 2008 | A1 |
| 20080288026 | Cross et al. | Nov 2008 | A1 |
| 20080309287 | Reed | Dec 2008 | A1 |
| 20090048556 | Durand | Feb 2009 | A1 |
| 20090062670 | Sterling et al. | Mar 2009 | A1 |
| 20090062671 | Brockway | Mar 2009 | A1 |
| 20090073991 | Landrum et al. | Mar 2009 | A1 |
| 20090076336 | Mazar et al. | Mar 2009 | A1 |
| 20090076340 | Libbus et al. | Mar 2009 | A1 |
| 20090076341 | James et al. | Mar 2009 | A1 |
| 20090076342 | Amurthur et al. | Mar 2009 | A1 |
| 20090076343 | James et al. | Mar 2009 | A1 |
| 20090076344 | Libbus et al. | Mar 2009 | A1 |
| 20090076345 | Manicka et al. | Mar 2009 | A1 |
| 20090076346 | James et al. | Mar 2009 | A1 |
| 20090076349 | Libbus et al. | Mar 2009 | A1 |
| 20090076350 | Bly et al. | Mar 2009 | A1 |
| 20090076364 | Libbus et al. | Mar 2009 | A1 |
| 20090076397 | Libbus et al. | Mar 2009 | A1 |
| 20090076401 | Mazar et al. | Mar 2009 | A1 |
| 20090076559 | Libbus et al. | Mar 2009 | A1 |
| 20090182204 | Semler et al. | Jul 2009 | A1 |
| 20090253975 | Tiegs | Oct 2009 | A1 |
| 20090292193 | Wijesiriwardana | Nov 2009 | A1 |
| 20090292194 | Libbus et al. | Nov 2009 | A1 |
| 20090306485 | Bell | Dec 2009 | A1 |
| 20100001541 | Sugiyama | Jan 2010 | A1 |
| 20100022864 | Cordero | Jan 2010 | A1 |
| 20100042113 | Mah | Feb 2010 | A1 |
| 20100049006 | Magar et al. | Feb 2010 | A1 |
| 20100051039 | Ferrara | Mar 2010 | A1 |
| 20100056881 | Libbus et al. | Mar 2010 | A1 |
| 20100057056 | Gurtner | Mar 2010 | A1 |
| 20100076533 | Dar et al. | Mar 2010 | A1 |
| 20100081913 | Cross et al. | Apr 2010 | A1 |
| 20100145359 | Keller | Jun 2010 | A1 |
| 20100191310 | Bly | Jul 2010 | A1 |
| 20100234716 | Engel | Sep 2010 | A1 |
| 20100249625 | Lin | Sep 2010 | A1 |
| 20100268103 | McNamara et al. | Oct 2010 | A1 |
| 20100312131 | Naware et al. | Dec 2010 | A1 |
| 20100331711 | Krauss et al. | Dec 2010 | A1 |
| 20110021937 | Hugh et al. | Jan 2011 | A1 |
| 20110087083 | Poeze et al. | Apr 2011 | A1 |
| 20110098583 | Pandia et al. | Apr 2011 | A1 |
| 20110119212 | De Bruin et al. | May 2011 | A1 |
| 20110144470 | Mazar et al. | Jun 2011 | A1 |
| 20110160601 | Wang et al. | Jun 2011 | A1 |
| 20110166468 | Prystowsky et al. | Jul 2011 | A1 |
| 20110190650 | McNair | Aug 2011 | A1 |
| 20110218415 | Chen | Sep 2011 | A1 |
| 20110237922 | Parker, III et al. | Sep 2011 | A1 |
| 20110237924 | McGusty et al. | Sep 2011 | A1 |
| 20110251504 | Tereshchenko et al. | Oct 2011 | A1 |
| 20110279963 | Kumar et al. | Nov 2011 | A1 |
| 20110306862 | Hayes-Gill | Dec 2011 | A1 |
| 20120029307 | Paquet et al. | Feb 2012 | A1 |
| 20120071730 | Romero | Mar 2012 | A1 |
| 20120071731 | Gottesman | Mar 2012 | A1 |
| 20120071743 | Todorov et al. | Mar 2012 | A1 |
| 20120083670 | Rotondo et al. | Apr 2012 | A1 |
| 20120088999 | Bishay et al. | Apr 2012 | A1 |
| 20120101396 | Solosko et al. | Apr 2012 | A1 |
| 20120108917 | Libbus et al. | May 2012 | A1 |
| 20120108920 | Bly et al. | May 2012 | A1 |
| 20120110226 | Vlach et al. | May 2012 | A1 |
| 20120110228 | Vlach et al. | May 2012 | A1 |
| 20120133162 | Sgobero | May 2012 | A1 |
| 20120172676 | Penders et al. | Jul 2012 | A1 |
| 20120197150 | Cao et al. | Aug 2012 | A1 |
| 20120209102 | Ylotalo et al. | Aug 2012 | A1 |
| 20120215123 | Kumar et al. | Aug 2012 | A1 |
| 20120220835 | Chung | Aug 2012 | A1 |
| 20120259233 | Chan et al. | Oct 2012 | A1 |
| 20120271141 | Davies | Oct 2012 | A1 |
| 20120310070 | Kumar et al. | Dec 2012 | A1 |
| 20120323257 | Sutton | Dec 2012 | A1 |
| 20120330126 | Hoppe et al. | Dec 2012 | A1 |
| 20130041273 | Houben et al. | Feb 2013 | A1 |
| 20130046151 | Bsoul et al. | Feb 2013 | A1 |
| 20130085347 | Manicka et al. | Apr 2013 | A1 |
| 20130096395 | Katra et al. | Apr 2013 | A1 |
| 20130116533 | Lian et al. | May 2013 | A1 |
| 20130116585 | Bouguerra | May 2013 | A1 |
| 20130144146 | Linker | Jun 2013 | A1 |
| 20130150698 | Hsu et al. | Jun 2013 | A1 |
| 20130158494 | Ong | Jun 2013 | A1 |
| 20130172763 | Wheeler | Jul 2013 | A1 |
| 20130191035 | Chon et al. | Jul 2013 | A1 |
| 20130225938 | Vlach | Aug 2013 | A1 |
| 20130225967 | Esposito | Aug 2013 | A1 |
| 20130226018 | Kumar et al. | Aug 2013 | A1 |
| 20130245415 | Kumar et al. | Sep 2013 | A1 |
| 20130245472 | Eveland | Sep 2013 | A1 |
| 20130253285 | Bly et al. | Sep 2013 | A1 |
| 20130274584 | Finlay et al. | Oct 2013 | A1 |
| 20130296680 | Linker | Nov 2013 | A1 |
| 20130300575 | Kurzweil et al. | Nov 2013 | A1 |
| 20130324868 | Kaib et al. | Dec 2013 | A1 |
| 20130331663 | Albert et al. | Dec 2013 | A1 |
| 20130331665 | Bly et al. | Dec 2013 | A1 |
| 20130338448 | Libbus et al. | Dec 2013 | A1 |
| 20140012154 | Mazar | Jan 2014 | A1 |
| 20140058280 | Chefles et al. | Feb 2014 | A1 |
| 20140094676 | Gani et al. | Apr 2014 | A1 |
| 20140094709 | Korzinov et al. | Apr 2014 | A1 |
| 20140100432 | Golda et al. | Apr 2014 | A1 |
| 20140171751 | Sankman et al. | Jun 2014 | A1 |
| 20140116825 | Kurzweil et al. | Jul 2014 | A1 |
| 20140206976 | Thompson et al. | Jul 2014 | A1 |
| 20140206977 | Bahney et al. | Jul 2014 | A1 |
| 20140275827 | Gill et al. | Sep 2014 | A1 |
| 20140275928 | Acquista et al. | Sep 2014 | A1 |
| 20140303647 | Sepulveda et al. | Oct 2014 | A1 |
| 20140330136 | Manicka et al. | Nov 2014 | A1 |
| 20150022372 | Vosch | Jan 2015 | A1 |
| 20150057512 | Kapoor | Feb 2015 | A1 |
| 20150073252 | Mazar | Mar 2015 | A1 |
| 20150081959 | Vlach et al. | Mar 2015 | A1 |
| 20150082623 | Felix et al. | Mar 2015 | A1 |
| 20150087921 | Felix et al. | Mar 2015 | A1 |
| 20150087922 | Bardy et al. | Mar 2015 | A1 |
| 20150087923 | Bardy et al. | Mar 2015 | A1 |
| 20150087933 | Gibson et al. | Mar 2015 | A1 |
| 20150087948 | Bishay et al. | Mar 2015 | A1 |
| 20150087949 | Felix et al. | Mar 2015 | A1 |
| 20150087950 | Felix et al. | Mar 2015 | A1 |
| 20150087951 | Felix et al. | Mar 2015 | A1 |
| 20150088007 | Bardy et al. | Mar 2015 | A1 |
| 20150088020 | Dreisbach et al. | Mar 2015 | A1 |
| 20150094556 | Geva et al. | Apr 2015 | A1 |
| 20150173671 | Paalasmaa et al. | Jun 2015 | A1 |
| 20150193595 | McNamara et al. | Jul 2015 | A1 |
| 20150223711 | Raeder et al. | Aug 2015 | A1 |
| 20150238107 | Acquista et al. | Aug 2015 | A1 |
| 20150289814 | Magar et al. | Oct 2015 | A1 |
| 20150297134 | Albert et al. | Oct 2015 | A1 |
| 20150327781 | Hernandez-Silverira et al. | Nov 2015 | A1 |
| 20150351689 | Adams | Dec 2015 | A1 |
| 20150351799 | Sepulveda et al. | Dec 2015 | A1 |
| 20150374244 | Yoo et al. | Dec 2015 | A1 |
| 20160022161 | Khair | Jan 2016 | A1 |
| 20160029906 | Tompkins et al. | Feb 2016 | A1 |
| 20160066808 | Hijazi | Mar 2016 | A1 |
| 20160085927 | Dettinger et al. | Mar 2016 | A1 |
| 20160085937 | Dettinger et al. | Mar 2016 | A1 |
| 20160086297 | Dettinger et al. | Mar 2016 | A1 |
| 20160098536 | Dettinger et al. | Apr 2016 | A1 |
| 20160098537 | Dettinger et al. | Apr 2016 | A1 |
| 20160113520 | Manera | Apr 2016 | A1 |
| 20160120433 | Hughes et al. | May 2016 | A1 |
| 20160120434 | Park et al. | May 2016 | A1 |
| 20160128597 | Lin et al. | May 2016 | A1 |
| 20160135746 | Kumar et al. | May 2016 | A1 |
| 20160149292 | Ganton | May 2016 | A1 |
| 20160157744 | Wu et al. | Jun 2016 | A1 |
| 20160166155 | Banet et al. | Jun 2016 | A1 |
| 20160192852 | Bozza et al. | Jul 2016 | A1 |
| 20160192855 | Geva et al. | Jul 2016 | A1 |
| 20160192856 | Lee | Jul 2016 | A1 |
| 20160198972 | Lee et al. | Jul 2016 | A1 |
| 20160232807 | Ghaffari et al. | Aug 2016 | A1 |
| 20160262619 | Marcus et al. | Sep 2016 | A1 |
| 20160287177 | Huppert et al. | Oct 2016 | A1 |
| 20160287207 | Xue | Oct 2016 | A1 |
| 20160296132 | Bojovic et al. | Oct 2016 | A1 |
| 20160302726 | Chang | Oct 2016 | A1 |
| 20160317048 | Chan et al. | Nov 2016 | A1 |
| 20160317057 | Li et al. | Nov 2016 | A1 |
| 20160367164 | Felix et al. | Dec 2016 | A1 |
| 20160374583 | Cerruti et al. | Dec 2016 | A1 |
| 20170042447 | Rossi | Feb 2017 | A1 |
| 20170055896 | Al-Ali et al. | Mar 2017 | A1 |
| 20170056682 | Kumar | Mar 2017 | A1 |
| 20170065823 | Kaib et al. | Mar 2017 | A1 |
| 20170076641 | Senanayake | Mar 2017 | A1 |
| 20170188872 | Hughes et al. | Jul 2017 | A1 |
| 20170188971 | Hughes et al. | Jul 2017 | A1 |
| 20180049698 | Berg | Feb 2018 | A1 |
| 20180146875 | Friedman et al. | May 2018 | A1 |
| 20180161211 | Beckey | Jun 2018 | A1 |
| 20180242876 | Hughes et al. | Aug 2018 | A1 |
| 20180257346 | Austin | Sep 2018 | A1 |
| 20180289274 | Bahney et al. | Oct 2018 | A1 |
| 20180374576 | Dettinger et al. | Dec 2018 | A1 |
| 20190021671 | Kumar et al. | Jan 2019 | A1 |
| 20190038148 | Valys | Feb 2019 | A1 |
| 20190046066 | Hughes et al. | Feb 2019 | A1 |
| 20190167143 | Li et al. | Jun 2019 | A1 |
| 20190209022 | Sobol | Jul 2019 | A1 |
| 20190246928 | Bahney et al. | Aug 2019 | A1 |
| 20190274574 | Hughes et al. | Sep 2019 | A1 |
| 20190282178 | Volosin et al. | Sep 2019 | A1 |
| 20190290147 | Persen et al. | Sep 2019 | A1 |
| 20190298201 | Persen et al. | Oct 2019 | A1 |
| 20190298209 | Persen et al. | Oct 2019 | A1 |
| 20190298272 | Persen | Oct 2019 | A1 |
| 20190374163 | Faabaek et al. | Dec 2019 | A1 |
| 20200060563 | Boleyn | Feb 2020 | A1 |
| 20200093388 | Bouguerra et al. | Mar 2020 | A1 |
| 20200121209 | Kumar et al. | Apr 2020 | A1 |
| 20200170529 | Bahney et al. | Jun 2020 | A1 |
| 20200178825 | Lu | Jun 2020 | A1 |
| 20200178828 | Bahney et al. | Jun 2020 | A1 |
| 20200193597 | Fan | Jun 2020 | A1 |
| 20200214563 | Lin | Jul 2020 | A1 |
| 20200214584 | McNamara et al. | Jul 2020 | A1 |
| 20200289014 | Park et al. | Sep 2020 | A1 |
| 20200352489 | Hoppe et al. | Nov 2020 | A1 |
| 20200367779 | Korzinov et al. | Nov 2020 | A1 |
| 20210217519 | Park et al. | Jul 2021 | A1 |
| 20210315504 | Kumar et al. | Oct 2021 | A1 |
| 20210361218 | Szabados et al. | Nov 2021 | A1 |
| 20220039719 | Abercrombie, II et al. | Feb 2022 | A1 |
| 20220039720 | Abercrombie, II et al. | Feb 2022 | A1 |
| Number | Date | Country |
|---|---|---|
| 2011252998 | Aug 2015 | AU |
| 2014209376 | Jun 2017 | AU |
| 2 752 154 | Aug 2010 | CA |
| 2 898 626 | Jul 2014 | CA |
| 2 797 980 | Aug 2015 | CA |
| 2 651 203 | Sep 2017 | CA |
| 2 966 182 | Jun 2020 | CA |
| 102883775 | Dec 2014 | CN |
| 103997955 | Nov 2016 | CN |
| 303936805 | Nov 2016 | CN |
| 107205679 | Sep 2017 | CN |
| 001857966-0001 | May 2011 | EM |
| 003611714-0001 | Jan 2017 | EM |
| 003611714-0002 | Jan 2017 | EM |
| 003611714-0003 | Jan 2017 | EM |
| 003611714-0004 | Jan 2017 | EM |
| 003611714-0005 | Jan 2017 | EM |
| 0 509 689 | Apr 1992 | EP |
| 1 738 686 | Jun 2006 | EP |
| 1 782 729 | May 2007 | EP |
| 1 981 402 | Oct 2008 | EP |
| 2 262 419 | Dec 2010 | EP |
| 2 395 911 | Dec 2011 | EP |
| 2 568 878 | Mar 2013 | EP |
| 2 635 179 | Sep 2013 | EP |
| 2 635 180 | Sep 2013 | EP |
| 2 948 050 | Dec 2015 | EP |
| 2 983 593 | Feb 2016 | EP |
| 3 165 161 | May 2017 | EP |
| 3 212 061 | Sep 2017 | EP |
| 3 753 483 | Dec 2020 | EP |
| 2 299 038 | Sep 1996 | GB |
| 2 348 707 | Oct 2000 | GB |
| 002592907-0001 | Dec 2014 | IN |
| S61-137539 | Jun 1986 | JP |
| H08-317913 | Mar 1996 | JP |
| 2000-126145 | May 2000 | JP |
| 2001-057967 | Mar 2001 | JP |
| 2004-121360 | Apr 2004 | JP |
| 2006-110180 | Apr 2006 | JP |
| 2007-045967 | Feb 2007 | JP |
| 2007-503910 | Mar 2007 | JP |
| 2007-504917 | Mar 2007 | JP |
| 2007-097822 | Apr 2007 | JP |
| 2007-296266 | Nov 2007 | JP |
| 2009-518099 | May 2009 | JP |
| 2009-525816 | Jul 2009 | JP |
| 2011-519583 | Jul 2011 | JP |
| 2013-521966 | Jun 2013 | JP |
| 5203973 | Jun 2013 | JP |
| 1483906 | Oct 2013 | JP |
| 5559425 | Jul 2014 | JP |
| 2014-236982 | Dec 2014 | JP |
| 2016-504159 | Feb 2016 | JP |
| 2013-517053 | May 2016 | JP |
| 2017-136380 | Aug 2017 | JP |
| 6198849 | Sep 2017 | JP |
| 6336640 | May 2018 | JP |
| D1596476 | Aug 2018 | JP |
| 2018-153651 | Oct 2018 | JP |
| 6491826 | Mar 2019 | JP |
| 6495228 | Mar 2019 | JP |
| 2020-058819 | Apr 2020 | JP |
| 6766199 | Sep 2020 | JP |
| 3003784570000 | Mar 2005 | KR |
| 1020050055072 | Jun 2005 | KR |
| 10-1513288 | Apr 2015 | KR |
| 3008476060000 | Mar 2016 | KR |
| 3008476090000 | Mar 2016 | KR |
| 3008482960000 | Mar 2016 | KR |
| 3008584120000 | Jun 2016 | KR |
| 3008953750000 | Feb 2017 | KR |
| 3008953760000 | Feb 2017 | KR |
| 3008987790000 | Mar 2017 | KR |
| 3009445870000 | Feb 2018 | KR |
| 3009547690000 | Apr 2018 | KR |
| 3009547710000 | Apr 2018 | KR |
| WO 99023943 | May 1999 | WO |
| WO 01016607 | Mar 2001 | WO |
| WO 2004100785 | Nov 2004 | WO |
| WO 2005025668 | Mar 2005 | WO |
| WO 2005037946 | Apr 2005 | WO |
| WO 2005084533 | Sep 2005 | WO |
| WO 2006094513 | Sep 2006 | WO |
| WO 2007049080 | Mar 2007 | WO |
| WO 2007036748 | Apr 2007 | WO |
| WO 2007063436 | Jun 2007 | WO |
| WO 2007071180 | Jun 2007 | WO |
| WO 2007072069 | Jun 2007 | WO |
| WO 2007092543 | Aug 2007 | WO |
| WO 2008005015 | Jan 2008 | WO |
| WO 2008005016 | Jan 2008 | WO |
| WO 2008057884 | May 2008 | WO |
| WO 2008120154 | Oct 2008 | WO |
| WO 2009055397 | Apr 2009 | WO |
| WO 2009074928 | Jun 2009 | WO |
| WO 2009112972 | Sep 2009 | WO |
| WO 2009112976 | Sep 2009 | WO |
| WO 2009112979 | Sep 2009 | WO |
| WO 2009134826 | Nov 2009 | WO |
| WO 2010014490 | Feb 2010 | WO |
| WO 2010104952 | Sep 2010 | WO |
| WO 2010105203 | Sep 2010 | WO |
| WO 2010093900 | Oct 2010 | WO |
| WO 2011077097 | Jun 2011 | WO |
| WO 2011084636 | Jul 2011 | WO |
| WO 2011112420 | Sep 2011 | WO |
| WO 2011143490 | Nov 2011 | WO |
| WO 2011149755 | Dec 2011 | WO |
| WO 2012009453 | Jan 2012 | WO |
| WO 2012061509 | May 2012 | WO |
| WO 2012061518 | May 2012 | WO |
| WO 2012125425 | Sep 2012 | WO |
| WO 2012160550 | Nov 2012 | WO |
| WO 2014047032 | Mar 2014 | WO |
| WO 2014051563 | Apr 2014 | WO |
| WO 2014055994 | Apr 2014 | WO |
| WO 2014116825 | Jul 2014 | WO |
| WO 2014168841 | Oct 2014 | WO |
| WO 2016044514 | Mar 2016 | WO |
| WO 2016044515 | Mar 2016 | WO |
| WO 2016044519 | Mar 2016 | WO |
| WO 2016057728 | Apr 2016 | WO |
| WO 2016070128 | May 2016 | WO |
| WO 2016181321 | Nov 2016 | WO |
| WO 2017039518 | Mar 2017 | WO |
| WO 2017041014 | Mar 2017 | WO |
| WO 2019191487 | Oct 2019 | WO |
| WO 2020013895 | Jan 2020 | WO |
| WO 2020041363 | Feb 2020 | WO |
| WO 2020224041 | Nov 2020 | WO |
| Entry |
|---|
| US 8,750,980 B2, 06/2014, Katra et al. (withdrawn) |
| Feng-Tso Sun et al., “PEAR: Power efficiency through activity recognition (for ECG-based sensing)”, Pervasive Computing Technologies for Healthcare (Pervasivehealth) 2011 5th International Conference On, IEEE, May 23, 2011. pp. 115-122. |
| Huyett “Keystock & Shim Stock Catalog” p. 9 Feb. 2014. found at https://issuu.com/glhuyett/docs/gl-huyett-keystock-catalog/20 (Year: 2014). |
| 3M Corporation, “3M Surgical Tapes—Choose the Correct Tape” quicksheet (2004). |
| Altini, et al., An ECG Patch Combining a Customized Ultra-Low-Power ECG SOC With Bluetooth Low Energy for Long Term Ambulatory Monitoring, Conference: Proceddings of Wireless Health 2011, WH 2011, Oct. 10-13, 2011. |
| British-Made Early Warning Monitor a “Game Changer”, healthcare-in-europe.com, Mar. 31, 2014. |
| Coxworth, Small Adhesive Partch Outperforms Traditional Tech for Detecting Arrhythmia, Scripps, iRhythm Technologies, Jan. 3, 2014. |
| Del Mar et al.; The history of clinical holter monitoring; A.N.E.; vol. 10; No. 2; pp. 226-230; Apr. 2005. |
| Design Search Project Overview as referenced in Petition to Request Expedited Examination. |
| English translation of Office Action for Japanese Application No. 2015-555272 dated Aug. 30, 2016. |
| Enseleit et al.; Long-term continuous external electrocardiographic recording: a review; Eurospace; vol. 8; pp. 255-266; 2006. |
| Hoefman et al.; Optimal duration of event recording for diagnosis of arrhythmias in patients with palpitations and light-headedness in the general practice; Family Practice; Dec. 7, 2006. |
| International Preliminary Report on Patentability and Written Opinion in PCT Application No. PCT/US07/003343, dated Aug. 12, 2008. |
| International Preliminary Report on Patentability and Written Opinion in PCT Application No. PCT/US2011/036335, dated Nov. 22, 2012. |
| International Preliminary Report on Patentability and Written Opinion in PCT Application No. PCT/US2014/012749, dated Aug. 6, 2015. |
| International Preliminary Report on Patentability and Written Opinion in PCT Application No. PCT/US2014/033064, dated Oct. 22, 2015. |
| International Preliminary Report on Patentability and Written Opinion in PCT Application No. PCT/US2015/058478, dated May 11, 2017. |
| International Search Report and Written Opinion in PCT Application No. PCT/US07/003343, as dated Feb. 28, 2008. |
| International Search Report and Written Opinion in PCT Application No. PCT/US2011/036335, dated Oct. 31, 2011. |
| International Search Report and Written Opinion in PCT Application No. PCT/US2014/012749, dated Mar. 21, 2014. |
| International Search Report and Written Opinion in PCT Application No. PCT/US2014/033064, dated Sep. 23, 2014. |
| International Search Report and Written Opinion for International Application No. PCT/US2015/058478 dated Feb. 16, 2016 in 12 pages. |
| Kennedy et al.; The history, science, and innovation of holter technology; A.N.E.; vol. 11; No. 1; pp. 85-94; 2006. |
| “Mayo Alumni”, Mayo Clinic, Rochester, MN, Spring 2011, in 24 pages. |
| Medtronic Launches SEEQ Wearable Cardiac Monitoring System in United States, Diagnostic and Interventional Cardiology, Oct. 7, 2014. |
| Mundt et al. “A Multiparameter Wearable Physiologic Monitoring System for Space and Terrestrial Applications” IEEE Transactions on Information Technology in Biomedicine, vol. 9, No. 3, pp. 382-384, Sep. 2005. |
| Official Communication received in European Search Report received in European Patent Application No. 11781310.5, dated Aug. 29, 2014. |
| PCT Search Report dated May 6, 2021 for International Patent Application No. PCT/US2021/017667. |
| Prakash, New Patch-Based Wearable Sensor Combines Advanced Skin Adhesives and Sensor Technologies, Advantage Business Marketing, Jul. 17, 2012. |
| Request for Reexamination of U.S. Pat. No. 7,020,508 under 35 U.S.C. §§ 311-318 and 37 C.F.R. § 1.913 as submitted Sep. 14, 2012 in 78 pages. |
| Scapa Medical product listing and descriptions (2008) available at http://www.caapana.com/productlist.jsp and http://www.metplus.co.rs/pdf/prospekti/Samolepljivemedicinsketrake.pdf; retrieved via WayBack Machine Sep. 24, 2012. |
| Sumner, Stanford Engineers Monitor Heart Health Using Paper-Thin Flexible ‘Skin’, Stanford Report, May 14, 2013. |
| Supplementary European Search Report received in European Patent Application No. 11781310.5, dated Jul. 30, 2014. |
| Supplementary European Search Report received in European Patent Application No. 114743121.7, dated Oct. 14, 2016. |
| Ward et al.; Assessment of the diagnostic value of 24-hour ambulatory electrocardiographic monitoring; Biotelemetry Patient monitoring; vol. 7; 1980. |
| Zimetbaum et al.; The evolving role of ambulatory arrhythmia monitoring in general clinic practice; Ann. Intern. Med.; vol. 130; pp. 846-8556; 1999. |
| Zimetbaum et al.; Utility of patient-activated cardiac event recorders in general clinical practice; The Amer. J. of Cardiology; vol. 79; Feb. 1, 1997. |
| Number | Date | Country | |
|---|---|---|---|
| 20220167905 A1 | Jun 2022 | US |
| Number | Date | Country | |
|---|---|---|---|
| 63090951 | Oct 2020 | US | |
| 62975626 | Feb 2020 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 17397075 | Aug 2021 | US |
| Child | 17651773 | US | |
| Parent | 17174145 | Feb 2021 | US |
| Child | 17397075 | US |
